Patent Grant
9440179
1. Field of the Invention
The present invention relates generally to health equipment and, more specifically, to oxygen concentrators.
2. Description of the Related Art
Many patients require supplemental oxygen as part of Long Term Oxygen Therapy (LTOT). Currently, the vast majority of patients that are receiving LTOT are diagnosed under the general category of Chronic Obstructive Pulmonary Disease, COPD. This general diagnosis includes such common diseases as Chronic Asthma, Emphysema, Congestive Heart Failure and several other cardio-pulmonary conditions. Other people (e.g., obese individuals) may also require supplemental oxygen, for example, to maintain elevated activity levels.
Doctors may prescribe oxygen concentrators or portable tanks of medical oxygen for these patients. Usually a specific oxygen flow rate is prescribed (e.g., 1 liter per minute (LPM), 2 LPM, 3 LPM, etc.). Experts in this field have also recognized that exercise for these patients provide long term benefits that slow the progression of the disease, improve quality of life and extend patient longevity. Most stationary forms of exercise like tread mills and stationary bicycles, however, are too strenuous for these patients. As a result, the need for mobility has long been recognized. Until recently, this mobility has been facilitated by the use of small compressed oxygen tanks. The disadvantage of these tanks is that they have a finite amount of oxygen and they are heavy, weighing about 50 pounds, when mounted on a cart with dolly wheels.
Oxygen concentrators have been in use for about 50 years to supply patients suffering from respiratory insufficiency with supplemental oxygen. Traditional oxygen concentrators used to provide these flow rates have been bulky and heavy making ordinary ambulatory activities with them difficult and impractical. Recently, companies that manufacture large stationary home oxygen concentrators began developing portable oxygen concentrators, POCs. The advantage of POCs concentrators was that they could produce a theoretically endless supply of oxygen. In order to make these devices small for mobility, the various systems necessary for the production of oxygen enriched gas are condensed.
Oxygen concentrators may include a compressor that has reciprocating members, for example, piston compressors and wobble compressors. These types of compressors employ a series of valves to force the air to be pushed in one direction. Piston and/or wobble compressors may involve the acceleration of the reciprocating member followed by deceleration to a standstill, and then reacceleration in the opposite direction. Each of these changes of direction require energy and that energy is wasted usually exhibiting itself as heat and sound energy that is unwanted. Heat may damage the oxygen concentrator separation components (for example, molecular sieve beds). In the case of battery powered portable oxygen concentrators, heat dissipation may harm or shorten the life of the battery. For example, lithium ion battery that does not tolerate heat well and may have protect circuits that turn the battery off in the event of heat buildup.
Over a period of time, compressor valves maybe a source of component failure. The valves may lose their ability to check to reverse flow of the air passing through the compressor. Thus, causing compressor efficiency to diminish and the production of oxygen is reduced, resulting in less oxygen purity in the oxygen concentrator output. Thus, a compressor that has minimum and longer durability is desired.
Due to the rapid actuation of valves in traditional piston or wobble compressors, a vibration in the auditory range is inherent. The valves consequently emit unwanted noise. This noise may be at a frequency that is different from the frequency emitted by the pistons. As a result, there is an additive nature to the overall sound coming from the compressor. Thus, compressors that operate silently or do not emit frequencies in an auditory range are desired.
The weight of portable oxygen concentrators is important as the oxygen concentrator may be carried. Several factors may contribute to the weight of the device in general. Many of these factors related to the efficiency of the compressor used in the oxygen concentrator. For example, a less efficient compressor requires greater size of the compression mechanism to produce the required amount of compression. The larger the fluid chambers of the compressor, the more the compressor weighs. A less efficient compressor requires a much higher torque output to drive the compressor. Thus, the compressor motors may be larger and heavier. A less efficient compressor may require more power, and thus designed run time from a battery pack may require a bigger and heavier battery pack. Less efficient compressors may also include heavy subcomponents (for example, bearings, motors and valves), which adds cost in addition to weight to the compressor.
As described above, it is desirable to provide an oxygen concentrator that includes a durable, highly efficient and light-weight compressor.
Systems and methods of providing an oxygen enriched gas to a user of an oxygen concentrator are described herein.
In some embodiments, an oxygen concentrator apparatus includes at least one canister, gas separation adsorbent disposed in at least one canister, and a compression system coupled to at least one canister. The gas separation adsorbent separates at least some nitrogen from air in the canister to produce oxygen enriched gas. The compression system includes at least one compressor coupled to the canister. The compressor includes a first rotor having at least two projections and a second rotor having at least two recesses. During rotation of the first and second rotors, gas is moved through the compressor to at least one of the canisters.
In some embodiments, a method of providing oxygen enriched gas to a user includes applying power to a drive transmission system of a compressor of an oxygen concentrator apparatus such that the drive transmission system rotates the first and second rotors in opposite directions. Rotation of the first and second rotors draws air into the compression system and discharges air to at least one canister of the oxygen concentrator apparatus. At least some nitrogen from air in the canister is separated to produce oxygen enriched gas.
Advantages of the present invention will become apparent to those skilled in the art with the benefit of the following detailed description of embodiments and upon reference to the accompanying drawings in which:
While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present invention as defined by the appended claims.
It is to be understood the present invention is not limited to particular devices or methods, which may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting. Headings are for organizational purposes only and are not meant to be used to limit or interpret the description or claims. As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include singular and plural referents unless the content clearly dictates otherwise. Furthermore, the word “may” is used throughout this application in a permissive sense (i.e., having the potential to, being able to), not in a mandatory sense (i.e., must). The term “include,” and derivations thereof, mean “including, but not limited to.”
The term “coupled” as used herein means either a direct connection or an indirect connection (e.g., one or more intervening connections) between one or more objects or components. The phrase “connected” means a direct connection between objects or components such that the objects or components are connected directly to each other. As used herein the phrase “obtaining” a device means that the device is either purchased or constructed.
Oxygen concentrators take advantage of pressure swing adsorption (PSA). Pressure swing adsorption involves using a compressor to increase gas pressure inside a canister that contains particles of a gas separation adsorbent. As the pressure increases, certain molecules in the gas may become adsorbed onto the gas separation adsorbent. Removal of a portion of the gas in the canister under the pressurized conditions allows separation of the non-adsorbed molecules from the adsorbed molecules. The gas separation adsorbent may be regenerated by reducing the pressure, which reverses the adsorption of molecules from the adsorbent. Further details regarding oxygen concentrators may be found, for example, in U.S. Published Patent Application No. 2009-0065007, published Mar. 12, 2009, and entitled “Oxygen Concentrator Apparatus and Method”, which is incorporated herein by reference.
Ambient air usually includes approximately 78% nitrogen and 21% oxygen with the balance comprised of argon, carbon dioxide, water vapor and other trace elements. If a gas mixture such as air, for example, is passed under pressure through a vessel containing a gas separation adsorbent bed that attracts nitrogen more strongly than it does oxygen, part or all of the nitrogen will stay in the bed, and the gas coming out of the vessel will be enriched in oxygen. When the bed reaches the end of its capacity to adsorb nitrogen, it can be regenerated by reducing the pressure, thereby releasing the adsorbed nitrogen. It is then ready for another cycle of producing oxygen enriched air. By alternating canisters in a two-canister system, one canister can be collecting oxygen while the other canister is being purged (resulting in a continuous separation of the oxygen from the nitrogen). In this manner, oxygen can be accumulated out of the air for a variety of uses including providing supplemental oxygen to patients.
Oxygen concentrator 100 may be a portable oxygen concentrator. For example, oxygen concentrator 100 may have a weight and size that allows the oxygen concentrator to be carried by hand and/or in a carrying case. In one embodiment, oxygen concentrator 100 has a weight of less than about 20 lbs., less than about 15 lbs., less than about 10 lbs., or less than about 5 lbs. In an embodiment, oxygen concentrator 100 has a volume of less than about 1000 cubic inches, less than about 750 cubic inches; less than about 500 cubic inches, less than about 250 cubic inches, or less than about 200 cubic inches.
Oxygen may be collected from ambient air by pressurizing ambient air in canisters 302 and 304, which include a gas separation adsorbent. Gas separation adsorbents useful in an oxygen concentrator are capable of separating at least nitrogen from an air stream to produce oxygen enriched gas. Examples of gas separation adsorbents include molecular sieves that are capable of separation of nitrogen from an air stream. Examples of adsorbents that may be used in an oxygen concentrator include, but are not limited to, zeolites (natural) or synthetic crystalline aluminosilicates that separate nitrogen from oxygen in an air stream under elevated pressure. Examples of synthetic crystalline aluminosilicates that may be used include, but are not limited to: OXYSIV adsorbents available from UOP LLC, Des Plaines, Iowa; SYLOBEAD adsorbents available from W. R. Grace & Co, Columbia, Md.; SILIPORITE adsorbents available from CECA S.A. of Paris, France; ZEOCHEM adsorbents available from Zeochem AG, Uetikon, Switzerland; and AgLiLSX adsorbent available from Air Products and Chemicals, Inc., Allentown, Pa.
As shown in
Compression system 200 may include one or more compressors capable of compressing air. In some embodiments, compression system may include one, two, three, four, or more compressors. Compression system 200 may include a compressor coupled to a motor. The motor provides an operating force to the compressor to operate the compression mechanism. Pressurized air, produced by compression system 200, may be forced into one or both of the canisters 302 and 304. In some embodiments, the ambient air may be pressurized in the canisters to a pressure approximately in a range of 13-20 pounds per square inch (psi). Other pressures may also be used, depending on the type of gas separation adsorbent disposed in the canisters.
In some embodiments, the compressor may be a piston compressor or a diaphragm compressor. The pressuring device may be a piston compressor that has multiple pistons. During operation, the pistons may be selectively turned on or off. In some embodiments, a motor may be coupled to multiple compressors. Each compressor may be selectively turned on or off. For example, controller 400 may determine which compressors or pistons should be operated based on predetermined operating conditions.
Dual Rotor Compressor
In some embodiments, the compressor of compression system 200 is a dual rotor compressor. A dual rotor compressor may have a continuous flow path and no reciprocation. The power consumption of a dual rotor compressor, as compared to a wobble piston compressor or piston compressor, for an oxygen concentrator is about one half A dual rotor compressor includes one rotor that provides the compression force and another rotor that seals the flow of air to prevent backflow. Thus, a dual rotor compressor may not require check valves to inhibit backflow of fluid. Elimination of check valves may enhance the durability of the compressor, as a check valve may be a source of wear and noise.
In a dual rotor compressor, continuous motion of the rotors may eliminate the constant acceleration and deceleration used by piston compressors. Thus, power consumption is lowered and noise reduction due to pulsing is eliminated. Continuous motion of the rotors is less stressful on the bearings in the compressor as compared to piston compressors. Since a dual rotor compressor is more efficient than piston compressor, less energy is dissipated as heat, and thus a dual rotor compressor may operate at lower temperatures than piston compressors. Thus, use of a rotary compressor in an oxygen concentrator provides a more efficient, durable and light-weight oxygen concentrator. U.S. Pat. No. 3,602,617 to Takaheshi and U.S. Pat. No. 4,747,762 to Fairbairn and U.S. Patent Application Publication No. to Simonds, both of which are incorporated herein by reference, describe rotary compressors,
Outer housing 706 includes two recesses that accommodate respective ball bearings 710, 712. The outer races of ball bearings 710, 712 may be positioned in the respective recesses (for example, press fitted) of the outer housing 706. Gear housing 704 includes two recesses that accommodate ball bearings 714, 716. The outer races of ball bearings 714, 716 may be positioned in the respective recesses (for example, press fitted) of gear housing 704.
First drive shaft 718 may be coupled (for example, press fitted) to the inner races of bearings 710, 714 and extend through cavity portion 720 of the interior of compressor housing 702. First rotor 722 is coupled to (for example, mounted on) first drive shaft 718 and is keyed for rotation with the first drive shaft. When assembled, first rotor 722 is located in cavity 720 (as shown in
Second drive shaft 728 may be coupled (for example, press fitted) to the inner races of bearings 712, 716 and extend through cavity portion 730 of the interior space of compressor housing 702. Second drive shaft 728 is substantially parallel to first drive shaft 718. Second rotor 732 is coupled (for example, mounted on) to second drive shaft 728 and is keyed for rotation with the second drive shaft. Second rotor 732 includes projections (vanes or blades) 734, 736. As shown, second rotor 732 has two projections. In some embodiments, second rotor has n number of projections. Projection 734 and projection 736 are diametrically opposed to each. Projections 734, 736 project radially outward from a surface of second rotor 732. Recesses 724, 726 are complimentary in shape to projections 734, 736. As rotors 722, 732 are rotated during use, projections 734, 736 enter and exit recesses 724, 726.
When assembled, second rotor 732 is located in cavity 730 (as shown in
Rotor housing 702 includes cavity portions 720, 730, inlet passage 738, outlet passage 740, and seals 742. Cavity portions 720, 730 of rotor housing 702 are complementary in shape and size to rotors 722, 732. As shown, cavity portions 720, 730 are substantially cylindrical in shape and intersect in a region X shown in
The radius of curvature of the cavity portion 720 in the regions Y (shown in
The radius of curvature of cavity portion 720 between the regions Y is somewhat greater than in the regions Y. This larger radius of curvature may facilitates manufacture of the compressor rotor housing as the tolerance on the dimensions of the peripheral surface of the upper cavity between the regions Y may then be greater than in the regions Y.
When second rotor 732 rotates within the cavity portion 730 of the interior space, a small clearance exists between the tip of projections 734,736 and the inner surface of the cavity. Thus, as second rotor 732 rotates, the tip of the projections are substantially adjacent to the inner surface of the cavity portion to form a substantially fluid-tight barrier therebetween. The cylindrical surface of cavity portion 730 extends at least 180 degrees about the central axis of second rotor 732 so that there is always at least one projection between the passage 738 and outlet passage 740. Outlet passage 740 coupled to inlet valves 122, 124 of oxygen concentrator 100.
Gear recess 744 (shown in
Drive pinion 752 is in meshing engagement with the spur gear 748 (shown in
During use, as shown in
Depending on the angular position of first rotor 722, second rotor 732, projection 734, and projection 736, two or three chambers are defined within cavity portion 730. At the 12 o'clock position, the portion of cavity 730 between projections 734, 736 and in fluid communication with inlet passage 738 forms inlet chamber 756. The portion of cavity 736 between projections 734, 736 and in fluid communication with outlet passage 740 forms outlet chamber 758.
As shown in
When projection 734 reaches the lower edge of inlet passage 738 (about the 3 o'clock position in
As rotors 722, 732 continues to rotate, the tip of projection 736 reaches the lower edge of the outlet passage 740 as shown in
In a conventional external gear compressor, the gear teeth divide the incoming flow of air into two streams, each of which is chopped by gear teeth into small volumes, which are subsequently combined. This manner of operation consumes energy, resulting in heating of the gas. In the case of the compressor illustrated in
In some embodiments, the external surfaces of the rotors and internal surfaces of the cavities of the rotary compressor 700 are in contact, thereby improving the rotor seal and the seals between the rotors and the compressor rotor housing. In order to minimize friction between surfaces, which would result in heating of the compressor components and possible bear of the compressor components, the surfaces may be provided with anti-friction coatings.
In some embodiments, a dual rotor compressor using in an oxygen concentrator may allow some fluid to enter the cavity during compression.
During use, rotor 732 rotates in a direction opposition of rotor 722, which allows projections 734, 736 to draw fluid through inlet 736, and into chamber 730. Fluid does not pass directly to outlet 740 because formation of a fluid barrier between the surfaces of rotors 722 and 732. The arrangement of rotors 722, 732 may be such that the projection 734 will enter the recess 724 during rotation and projection 736 will enter recess 726. Profiles of the projections 734, 736 and recesses 724,726 are complementary to allow maintaining at least one point of contact during the period that a projection is in a recess. At this point, the fluid that has entered cavity 730 may be under the influence of both of projections 734, 736 and further rotation of the shafts 718,728 will displace the fluid around the chamber until the point where the leading projection 734 passes the outlet 740 and the fluid may exit the outlet.
Inlet 736 discharges into a first zone defined between the peripheral surface of the chamber 730 and the cylindrical surfaces of rotors 722, 732 during rotation of the rotors. Fluid barrier 762 may be formed when cylindrical surfaces of rotor 722, 732 are in close proximity to each other. Inlet 736 may be orientated that to direct fluid in a direction around rotor 732 and away from fluid barrier 762. Outlet 740 communicates directly with a second zone defined between the peripheral surface of cavity 730 and the cylindrical surfaces of the rotors 722, 732 at the other side of the fluid barrier 762. Outlet 740 may be oriented to face in the direction of fluid being moved around the rotor 732. This configuration of the inlet and outlet contributes significantly to the efficiency of the compressor. Inlet 736 and outlet 740 are symmetrically arranged about a plane containing the axes of two rotors 722, 732 and are angularly displaced about the axis of the rotor 732, by an angle of substantially 270 degrees between the inlet and outlet.
When the projection moves into the recess, the profiles of projections 734, 736 and recesses 724, 726 obviate trapping of fluid within the recess at the outlet side. Instead, fluid within a recess near the outlet is progressively expelled from the recess by the projection when the projection moves into the recess. Thus, the efficiency of the compressor is enhanced because fluid is inhibited from being trapped in the recess. Similarly, at the inlet side, the projection moves out of the recess without creating a closed vacuum pocket within the recess.
Rotors 722,732 have a number of holes 764 there through, which align with holes in their respective gears. Holes 764 may equalize the pressure on either axial side of the rotors 722,732. Equalizing the pressure may eliminate side thrusts on the rotors and gears, which would tend to increase friction against the casing, and thus make rotation more difficult with a consequent reduction in efficiency of the compressor.
In some embodiments, a rotary compressor may have more than one rotor component.
In some embodiments, rotors 812 and 814 include at least two rotor components. As shown in
Rotors 812 and 814 include projections 836 and recesses 838. Each rotor component includes at least two projections 836A, 836B and two recesses 838A, 838B. Projections 836A, 836B extend from the peripheral surface of the rotors and are opposed (for example, positioned at about a 90 degree angle to each other). Recesses 838A and 838B may be positioned in the rotor at about a 45 degree angle from projections 836A and 836B. Rotor components 812A, 812B, 812C and 814A, 814B, 814C are combined to fix with their phase angles shifting at 60 degrees. Gears 840, 842 are mounted on the shafts 832, 834 respectively, to mesh each other.
During operation, an electric motor (not shown) may drive shaft 832. Gears 840, 842 may cooperate to drive shaft 834 and force rotor components 812A, 812B, 812C and 814A, 814B, 814C to revolve so that the projections 836A and 836B of each upper or lower rotor will fit into the recesses 838A and 838B of each lower or upper rotor. Revolution of the rotors draws fluid into cavity 810 from inlet 828, and through fluid chamber 824. The fluid may be forced onward along the circular inside wall of cavity 810, through fluid chamber 826, and then exit outlet 830 to canister 302/304.
Referring back to
In some embodiments, a two-step valve actuation voltage may be used to control inlet valves 122/124 and outlet valves 132/134. For example, a high voltage (e.g., 24 V) may be applied to an inlet valve to open the inlet valve. The voltage may then be reduced (e.g., to 7 V) to keep the inlet valve open. Using less voltage to keep a valve open may use less power (Power=Voltage*Current). This reduction in voltage minimizes heat buildup and power consumption to extend run time from the battery. When the power is cut off to the valve, it closes by spring action. In some embodiments, the voltage may be applied as a function of time that is not necessarily a stepped response (e.g., a curved downward voltage between an initial 24 V and a final 7 V).
In some embodiments, air may be pulled into the oxygen concentrator through two compressors. In some embodiments, air may flow from at least two compressors to canisters 302, 304. In some embodiments, one of valves 122 or 124 may be closed (e.g., as signaled by controller 400) resulting in the combined output of both compressors lowing through the other respective valve 122 or 124 into a respective canister 302, 304. For example, if valve 124 is closed, the air from both compressors may flow through valve 122. If valve 122 is closed, the air from both compressors may flow through valve 124. In some embodiments, valve 122 and valve 124 may alternate to alternately direct the air from the two compressors into respective canisters 302 or 304.
In an embodiment, pressurized air is sent into one of canisters 302 or 304 while the other canister is being vented. For example, during use, inlet valve 122 is opened while inlet valve 124 is closed. Pressurized air from compression system 200 is forced into canister 302, while being inhibited from entering canister 304 by inlet valve 124. In an embodiment, a controller 400 is electrically coupled to valves 122, 124, 132, and 134. Controller 400 includes one or more processors 410 operable to execute program instructions stored in memory 420. The program instructions are operable to perform various predefined methods that are used to operate the oxygen concentrator. Controller 400 may include program instructions for operating inlet valves 122 and 124 out of phase with each other, i.e., when one of inlet valves 122 or 124 is opened, the other valve is closed. During pressurization of canister 302, outlet valve 132 is closed and outlet valve 134 is opened. Similar to the inlet valves, outlet valves 132 and 134 are operated out of phase with each other. In some embodiments, the voltages and the duration of the voltages used to open the input and output valves may be controlled by controller 400.
Check valves 142 and 144 are coupled to canisters 302 and 304, respectively. Check valves 142 and 144 are one way valves that are passively operated by the pressure differentials that occur as the canisters are pressurized and vented. Check valves 142 and 144 are coupled to canisters to allow oxygen produced during pressurization of the canister to flow out of the canister, and to inhibit back flow of oxygen or any other gases into the canister. In this manner, check valves 142 and 144 act as one way valves allowing oxygen enriched gas to exit the respective canister during pressurization.
The term “check valve”, as used herein, refers to a valve that allows flow of a fluid (gas or liquid) in one direction and inhibits back flow of the fluid. Examples of check valves that are suitable for use include, but are not limited to: a ball check valve; a diaphragm check valve; a butterfly check valve; a swing check valve; a duckbill valve; and a lift check valve. Under pressure, nitrogen molecules in the pressurized ambient air are adsorbed by the gas separation adsorbent in the pressurized canister. As the pressure increases, more nitrogen is adsorbed until the gas in the canister is enriched in oxygen. The nonadsorbed gas molecules (mainly oxygen) flow out of the pressurized canister when the pressure reaches a point sufficient to overcome the resistance of the check valve coupled to the canister. In one embodiment, the pressure drop of the check valve in the forward direction is less than 1 psi. The break pressure in the reverse direction is greater than 100 psi. It should be understood, however, that modification of one or more components would alter the operating parameters of these valves. If the forward flow pressure is increased, there is, generally, a reduction in oxygen enriched gas production. If the break pressure for reverse flow is reduced or set too low, there is, generally, a reduction in oxygen enriched gas pressure.
In an exemplary embodiment, canister 302 is pressurized by compressed air produced in compression system 200 and passed into canister 302. During pressurization of canister 302 inlet valve 122 is open, outlet valve 132 is closed, inlet valve 124 is closed and outlet valve 134 is open. Outlet valve 134 is opened when outlet valve 132 is closed to allow substantially simultaneous venting of canister 304 while canister 302 is pressurized. Canister 302 is pressurized until the pressure in canister is sufficient to open check valve 142. Oxygen enriched gas produced in canister 302 exits through check valve and, in one embodiment, is collected in accumulator 106.
After some time the gas separation adsorbent will become saturated with nitrogen and will be unable to separate significant amounts of nitrogen from incoming air. This point is usually reached after a predetermined time of oxygen enriched gas production. In the embodiment described above, when the gas separation adsorbent in canister 302 reaches this saturation point, the inflow of compressed air is stopped and canister 302 is vented to remove nitrogen. During venting, inlet valve 122 is closed, and outlet valve 132 is opened. While canister 302 is being vented, canister 304 is pressurized to produce oxygen enriched gas in the same manner described above. Pressurization of canister 304 is achieved by closing outlet valve 134 and opening inlet valve 124. The oxygen enriched gas exits canister 304 through check valve 144.
During venting of canister 302, outlet valve 132 is opened allowing pressurized gas (mainly nitrogen) to exit the canister through concentrator outlet 130. In an embodiment, the vented gases may be directed through muffler 133 to reduce the noise produced by releasing the pressurized gas from the canister. As gas is released from canister 302, pressure in the canister drops. The drop in pressure may allow the nitrogen to become desorbed from the gas separation adsorbent. The released nitrogen exits the canister through outlet 130, resetting the canister to a state that allows renewed separation of oxygen from an air stream. Muffler 133 may include open cell foam (or another material) to muffle the sound of the gas leaving the oxygen concentrator. In some embodiments, the combined muffling components/techniques for the input of air and the output of gas may provide for oxygen concentrator operation at a sound level below 50 decibels.
During venting of the canisters, it is advantageous that at least a majority of the nitrogen is removed. In an embodiment, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, at least about 95%, at least about 98%, or substantially all of the nitrogen in a canister is removed before the canister is re-used to separate oxygen from air. In some embodiments, a canister may be further purged of nitrogen using an oxygen enriched stream that is introduced into the canister from the other canister.
In an exemplary embodiment, a portion of the oxygen enriched gas may be transferred from canister 302 to canister 304 when canister 304 is being vented of nitrogen. Transfer of oxygen enriched gas from canister 302 to 304, during venting of canister 304, helps to further purge nitrogen (and other gases) from the canister. In an embodiment, oxygen enriched gas may travel through flow restrictors 151, 153, and 155 between the two canisters. Flow restrictor 151 may be a trickle flow restrictor. Flow restrictor 151, for example, may be a 0.009D flow restrictor (e.g., the flow restrictor has a radius of 0.009 inches which is less than the diameter of the tube it is inside). Flow restrictors 153 and 155 may be 0.013D flow restrictors. Other flow restrictor types and sizes are also contemplated and may be used depending on the specific configuration and tubing used to couple the canisters. In some embodiments, the flow restrictors may be press fit flow restrictors that restrict air flow by introducing a narrower diameter in their respective tube. In some embodiments, the press fit flow restrictors may be made of sapphire, metal or plastic (other materials are also contemplated).
Flow of oxygen enriched gas is also controlled by use of valve 152 and valve 154. Valves 152 and 154 may be opened for a short duration during the venting process (and may be closed otherwise) to prevent excessive oxygen loss out of the purging canister. Other durations are also contemplated. In an exemplary embodiment, canister 302 is being vented and it is desirable to purge canister 302 by passing a portion of the oxygen enriched gas being produced in canister 304 into canister 302. A portion of oxygen enriched gas, upon pressurization of canister 304, will pass through flow restrictor 151 into canister 302 during venting of canister 302. Additional oxygen enriched air is passed into canister 302, from canister 304, through valve 154 and flow restrictor 155. Valve 152 may remain closed during the transfer process, or may be opened if additional oxygen enriched gas is needed. The selection of appropriate flow restrictors 151 and 155, coupled with controlled opening of valve 154 allows a controlled amount of oxygen enriched gas to be sent from canister 304 to 302. In an embodiment, the controlled amount of oxygen enriched gas is an amount sufficient to purge canister 302 and minimize the loss of oxygen enriched gas through venting valve 132 of canister 302. While this embodiment describes venting of canister 302, it should be understood that the same process can be used to vent canister 304 using flow restrictor 151, valve 152 and flow restrictor 153.
The pair of equalization/vent valves 152/154 work with flow restrictors 153 and 155 to optimize the air flow balance between the two canisters. This may allow for better flow control for venting the canisters with oxygen enriched gas from the other of the canisters. It may also provide better flow direction between the two canisters. It has been found that, while flow valves 152/154 may be operated as bi-directional valves, the flow rate through such valves varies depending on the direction of fluid flowing through the valve. For example, oxygen enriched gas flowing from canister 304 toward canister 302 has a flow rate faster through valve 152 than the flow rate of oxygen enriched gas flowing from canister 302 toward canister 304 through valve 152. If a single valve was to be used, eventually either too much or too little oxygen enriched gas would be sent between the canisters and the canisters would, over time, begin to produce different amounts of oxygen enriched gas. Use of opposing valves and flow restrictors on parallel air pathways may equalize the flow pattern of the oxygen between the two canisters. Equalizing the flow may allow for a steady amount of oxygen available to the user over multiple cycles and also may allow a predictable volume of oxygen to purge the other of the canisters. In some embodiments, the air pathway may not have restrictors but may instead have a valve with a built in resistance or the air pathway itself may have a narrow radius to provide resistance.
At times, oxygen concentrator may be shut down for a period of time. When an oxygen concentrator is shut down, the temperature inside the canisters may drop as a result of the loss of adiabatic heat from the compression system. As the temperature drops, the volume occupied by the gases inside the canisters will drop. Cooling of the canisters may lead to a negative pressure in the canisters. Valves (e.g., valves 122, 124, 132, and 134) leading to and from the canisters are dynamically sealed rather than hermetically sealed. Thus, outside air may enter the canisters after shutdown to accommodate the pressure differential. When outside air enters the canisters, moisture from the outside air may condense inside the canister as the air cools. Condensation of water inside the canisters may lead to gradual degradation of the gas separation adsorbents, steadily reducing ability of the gas separation adsorbents to produce oxygen enriched gas.
In an embodiment, outside air may be inhibited from entering canisters after the oxygen concentrator is shut down by pressurizing both canisters prior to shut down. By storing the canisters under a positive pressure, the valves may be forced into a hermetically closed position by the internal pressure of the air in the canisters. In an embodiment, the pressure in the canisters, at shutdown, should be at least greater than ambient pressure. As used herein the term “ambient pressure” refers to the pressure of the surroundings that the oxygen generator is located (e.g. the pressure inside a room, outside, in a plane, etc.). In an embodiment, the pressure in the canisters, at shutdown, is at least greater than standard atmospheric pressure (i.e., greater than 760 mmHg (Torr), 1 atm, 101,325 Pa). In an embodiment, the pressure in the canisters, at shutdown, is at least about 1.1 times greater than ambient pressure; is at least about 1.5 times greater than ambient pressure; or is at least about 2 times greater than ambient pressure.
In an embodiment, pressurization of the canisters may be achieved by directing pressurized air into each canister from the compression system and closing all valves to trap the pressurized air in the canisters. In an exemplary embodiment, when a shutdown sequence is initiated, inlet valves 122 and 124 are opened and outlet valves 132 and 134 are closed. Because inlet valves 122 and 124 are joined together by a common conduit, both canisters 302 and 304 may become pressurized as air and or oxygen enriched gas from one canister may be transferred to the other canister. This situation may occur when the pathway between the compression system and the two inlet valves allows such transfer. Because the oxygen generator operates in an alternating pressurize/venting mode, at least one of the canisters should be in a pressurized state at any given time. In an alternate embodiment, the pressure may be increased in each canister by operation of compression system 200. When inlet valves 122 and 124 are opened, pressure between canisters 302 and 304 will equalize, however, the equalized pressure in either canister may not be sufficient to inhibit air from entering the canisters during shutdown. In order to ensure that air is inhibited from entering the canisters, compression system 200 may be operated for a time sufficient to increase the pressure inside both canisters to a level at least greater than ambient pressure. Regardless of the method of pressurization of the canisters, once the canisters are pressurized, inlet valves 122 and 124 are closed, trapping the pressurized air inside the canisters, which inhibits air from entering the canisters during the shutdown period.
An outlet system, coupled to one or more of the canisters, includes one or more conduits for providing oxygen enriched gas to a user. In an embodiment, oxygen enriched gas produced in either of canisters 302 and 304 is collected in accumulator 106 through check valves 142 and 144, respectively, as depicted schematically in
Turning to
Oxygen enriched gas in accumulator 106 passes through supply valve 160 into expansion chamber 170 as depicted in
The fluid dynamics of the outlet pathway, coupled with the programmed actuations of supply valve 160, results in a bolus of oxygen being provided at the correct time and with a flow profile that assures rapid delivery into the patient's lungs without any excessive flow rates that would result in wasted retrograde flow out the nostrils and into the atmosphere. It has been found, in our specific system, that the total volume of the bolus required for prescriptions is equal to 11 mL for each LPM, i.e., 11 mL for a prescription of 1 LPM; 22 mL for a prescription of 2 LPM; 33 mL for a prescription of 3 LPM; 44 mL for a prescription of 4 LPM; 55 mL for a prescription of 5 LPM; etc. This is generally referred to as the LPM equivalent. It should be understood that the LPM equivalent may vary between apparatus due to differences in construction design, tubing size, chamber size, etc.
Expansion chamber 170 may include one or more oxygen sensors capable of being used to determine an oxygen concentration of gas passing through the chamber. In an embodiment, the oxygen concentration of gas passing through expansion chamber 170 is assessed using oxygen sensor 165. An oxygen sensor is a device capable of detecting oxygen in a gas. Examples of oxygen sensors include, but are not limited to, ultrasonic oxygen sensors, electrical oxygen sensors, and optical oxygen sensors. In one embodiment, oxygen sensor 165 is an ultrasonic oxygen sensor that includes ultrasonic emitter 166 and ultrasonic receiver 168. In some embodiments, ultrasonic emitter 166 may include multiple ultrasonic emitters and ultrasonic receiver 168 may include multiple ultrasonic receivers. In embodiments having multiple emitters/receivers, the multiple ultrasonic emitters and multiple ultrasonic receivers may be axially aligned (e.g., across the gas mixture flow path which may be perpendicular to the axial alignment).
In use, an ultrasonic sound wave (from emitter 166) may be directed through oxygen enriched gas disposed in chamber 170 to receiver 168. Ultrasonic sensor assembly may be based on detecting the speed of sound through the gas mixture to determine the composition of the gas mixture (e.g., the speed of sound is different in nitrogen and oxygen). In a mixture of the two gases, the speed of sound through the mixture may be an intermediate value proportional to the relative amounts of each gas in the mixture. In use, the sound at the receiver 168 is slightly out of phase with the sound sent from emitter 166. This phase shift is due to the relatively slow velocity of sound through a gas medium as compared with the relatively fast speed of the electronic pulse through wire. The phase shift, then, is proportional to the distance between the emitter and the receiver and the speed of sound through the expansion chamber. The density of the gas in the chamber affects the speed of sound through the chamber and the density is proportional to the ratio of oxygen to nitrogen in the chamber. Therefore, the phase shift can be used to measure the concentration of oxygen in the expansion chamber. In this manner the relative concentration of oxygen in the accumulation chamber may be assessed as a function of one or more properties of a detected sound wave traveling through the accumulation chamber.
In some embodiments, multiple emitters 166 and receivers 168 may be used. The readings from the emitters 166 and receivers 168 may be averaged to cancel errors that may be inherent in turbulent flow systems. In some embodiments, the presence of other gases may also be detected by measuring the transit time and comparing the measured transit time to predetermined transit times for other gases and/or mixtures of gases.
The sensitivity of the ultrasonic sensor system may be increased by increasing the distance between emitter 166 and receiver 168, for example to allow several sound wave cycles to occur between emitter 166 and the receiver 168. In some embodiments, if at least two sound cycles are present, the influence of structural changes of the transducer may be reduced by measuring the phase shift relative to a fixed reference at two points in time. If the earlier phase shift is subtracted from the later phase shift, the shift caused by thermal expansion of expansion chamber 170 may be reduced or cancelled. The shift caused by a change of the distance between emitter 166 and receiver 168 may be the approximately the same at the measuring intervals, whereas a change owing to a change in oxygen concentration may be cumulative. In some embodiments, the shift measured at a later time may be multiplied by the number of intervening cycles and compared to the shift between two adjacent cycles. Further details regarding sensing of oxygen in the expansion chamber may be found, for example, in U.S. Published Patent Application No. 2009-0065007, published Mar. 12, 2009, and entitled “Oxygen Concentrator Apparatus and Method, which is incorporated herein by reference.
Flow rate sensor 185 may be used to determine the flow rate of gas flowing through the outlet system. Flow rate sensors that may be used include, but are not limited to: diaphragm/bellows flow meters; rotary flow meters (e.g. Hall Effect flow meters); turbine flow meters; orifice flow meters; and ultrasonic flow meters. Flow rate sensor 185 may be coupled to controller 400. The rate of gas flowing through the outlet system may be an indication of the breathing volume of the user. Changes in the flow rate of gas flowing through the outlet system may also be used to determine a breathing rate of the user. Controller 400 may control actuation of supply valve 160 based on the breathing rate and/or breathing volume of the user, as assessed by flow rate sensor 185
In some embodiments, ultrasonic sensor system 165 and, for example, flow rate sensor 185 may provide a measurement of an actual amount of oxygen being provided. For example, follow rate sensor 185 may measure a volume of gas (based on flow rate) provided and ultrasonic sensor system 165 may provide the concentration of oxygen of the gas provided. These two measurements together may be used by controller 400 to determine an approximation of the actual amount of oxygen provided to the user.
Oxygen enriched gas passes through flow meter 185 to filter 187. Filter 187 removes bacteria, dust, granule particles, etc. prior to providing the oxygen enriched gas to the user. The filtered oxygen enriched gas passes through filter 187 to connector 190. Connector 190 may be a “Y” connector coupling the outlet of filter 187 to pressure sensor 194 and outlet conduit 192. Pressure sensor 194 may be used to monitor the pressure of the gas passing through conduit 192 to the user. Changes in pressure, sensed by pressure sensor 194, may be used to determine a breathing rate of a user, as well as the onset of inhalation. Controller 400 may control actuation of supply valve 160 based on the breathing rate and/or onset of inhalation of the user, as assessed by pressure sensor 194. In an embodiment, controller 400 may control actuation of supply valve 160 based on information provided by flow rate sensor 185 and pressure sensor 194.
Oxygen enriched gas may be provided to a user through conduit 192. In an embodiment, conduit 192 may be a silicone tube. Conduit 192 may be coupled to a user using an airway coupling member 196, as depicted in
Canister System
Oxygen concentrator system 100 may include at least two canisters, each canister including a gas separation adsorbent. The canisters of oxygen concentrator system 100 may be disposed formed from a molded housing. In an embodiment, canister system 300 includes two housing components 310 and 510, as depicted in
As shown, valve seats 320, 322, 324, and 326 and air pathways 330 and 332 may be integrated into the housing component 310 to reduce the number of sealed connections needed throughout the air flow of the oxygen concentrator 100. In various embodiments, the housing components 310 and 410 of the oxygen concentrator 100 may form a two-part molded plastic frame that defines two canisters 302 and 304 and accumulation chamber 106.
Air pathways/tubing between different sections in housing components 310 and 510 may take the form of molded conduits. Conduits in the form of molded channels for air pathways may occupy multiple planes in housing components 310 and 510. For example, the molded air conduits may be formed at different depths and at different x,y,z positions in housing components 310 and 510. In some embodiments, a majority or substantially all of the conduits may be integrated into the housing components 310 and 510 to reduce potential leak points.
In some embodiments, prior to coupling housing components 310 and 510 together, O-rings may be placed between various points of housing components 310 and 510 to ensure that the housing components are properly sealed. In some embodiments, components may be integrated and/or coupled separately to housing components 310 and 510. For example, tubing, flow restrictors (e.g., press fit flow restrictors), oxygen sensors, gas separation adsorbents 139, check valves, plugs, processors, power supplies, etc. may be coupled to housing components 510 and 410 before and/or after the housing components are coupled together.
In some embodiments, apertures 337 leading to the exterior of housing components 310 and 410 may be used to insert devices such as flow restrictors. Apertures may also be used for increased moldability. One or more of the apertures may be plugged after molding (e.g., with a plastic plug). In some embodiments, flow restrictors may be inserted into passages prior to inserting plug to seal the passage. Press fit flow restrictors may have diameters that may allow a friction fit between the press fit flow restrictors and their respective apertures. In some embodiments, an adhesive may be added to the exterior of the press fit flow restrictors to hold the press fit flow restrictors in place once inserted. In some embodiments, the plugs may have a friction fit with their respective tubes (or may have an adhesive applied to their outer surface). The press fit flow restrictors and/or other components may be inserted and pressed into their respective apertures using a narrow tip tool or rod (e.g., with a diameter less than the diameter of the respective aperture). In some embodiments, the press fit flow restrictors may be inserted into their respective tubes until they abut a feature in the tube to halt their insertion. For example, the feature may include a reduction in radius. Other features are also contemplated (e.g., a bump in the side of the tubing, threads, etc.). In some embodiments, press fit flow restrictors may be molded into the housing components (e.g., as narrow tube segments).
In some embodiments, spring baffle 129 may be placed into respective canister receiving portions of housing component 310 and 510 with the spring side of the baffle 129 facing the exit of the canister. Spring baffle 129 may apply force to gas separation adsorbent 139 in the canister while also assisting in preventing gas separation adsorbent 139 from entering the exit apertures. Use of a spring baffle 129 may keep the gas separation adsorbent compact while also allowing for expansion (e.g., thermal expansion). Keeping the gas separation adsorbent 139 compact may prevent the gas separation adsorbent from breaking during movement of the oxygen concentrator system 100).
In some embodiments, pressurized air from the compression system 200 may enter air inlet 306. Air inlet 306 is coupled to inlet conduit 330. Air enters housing component 310 through inlet 306 travels through conduit 330, and then to valve seats 322 and 324.
In an embodiment, pressurized air is sent into one of canisters 302 or 304 while the other canister is being vented. For example, during use, inlet valve 122 is opened while inlet valve 124 is closed. Pressurized air from compression system 200 is forced into canister 302, while being inhibited from entering canister 304 by inlet valve 124. During pressurization of canister 302, outlet valve 132 is closed and outlet valve 134 is opened. Similar to the inlet valves, outlet valves 132 and 134 are operated out of phase with each other. Each inlet valve seat 322 includes an opening 375 that passes through housing 310 into canister 302. Similarly valve seat 324 includes an opening 325 that passes through housing 310 into canister 302. Air from conduit 330 passes through openings 323, or 325 if the respective valve (322 or 324) is open, and enters a canister.
Check valves 142 and 144 (See,
Oxygen enriched gas from either canister, travels through conduit 342 or 344 and enters conduit 346 formed in housing 310. Conduit 346 includes openings that couple the conduit to conduit 342, conduit 344 and accumulator 106. Thus oxygen enriched gas, produced in canister 302 or 304, travels to conduit 346 and passes into accumulator 106.
After some time the gas separation adsorbent will become saturated with nitrogen and will be unable to separate significant amounts of nitrogen from incoming air. When the gas separation adsorbent in a canister reaches this saturation point, the inflow of compressed air is stopped and the canister is vented to remove nitrogen. Canister 302 is vented by closing inlet valve 122 and opening outlet valve 132. Outlet valve 132 releases the vented gas from canister 302 into the volume defined by the end of housing 310. Foam material may cover the end of housing 310 to reduce the sound made by release of gases from the canisters. Similarly, canister 304 is vented by closing inlet valve 124 and opening outlet valve 134. Outlet valve 134 releases the vented gas from canister 304 into the volume defined by the end of housing 310.
While canister 302 is being vented, canister 304 is pressurized to produce oxygen enriched gas in the same manner described above. Pressurization of canister 304 is achieved by closing outlet valve 134 and opening inlet valve 124. The oxygen enriched gas exits canister 304 through check valve 144.
In an exemplary embodiment, a portion of the oxygen enriched gas may be transferred from canister 302 to canister 304 when canister 304 is being vented of nitrogen. Transfer of oxygen enriched gas from canister 302 to canister 304, during venting of canister 304, helps to further purge nitrogen (and other gases) from the canister. Flow of oxygen enriched gas between the canisters is controlled using flow restrictors and valves, as depicted in
Oxygen enriched gas in accumulator 106 passes through supply valve 160 into expansion chamber 170 which is formed in housing 510. An opening (not shown) in housing 510 couples accumulator 106 to supply valve 160. In an embodiment, expansion chamber may include one or more devices capable of being used to determine an oxygen concentration of gas passing through the chamber.
Controller System
Operation of oxygen concentrator system 100 may be performed automatically using an internal controller 400 coupled to various components of the oxygen concentrator system, as described herein. Controller 400 includes one or more processors 410 and internal memory 420, as depicted in
In some embodiments, controller 400 includes processor 410 that includes, for example, one or more field programmable gate arrays (FPGAs), microcontrollers, etc. included on a circuit board disposed in oxygen concentrator system 100. Processor 410 is capable of executing programming instructions stored in memory 420. In some embodiments, programming instructions may be built into processor 410 such that a memory external to the processor may not be separately accessed (i.e., the memory 420 may be internal to the processor 410).
Processor 410 may be coupled to various components of oxygen concentrator system 100, including, but not limited to compression system 200, one or more of the valves used to control fluid flow through the system (e.g., valves 122, 124, 132, 134, 152, 154, 160, or combinations thereof), oxygen sensor 165, pressure sensor 194, flow rate monitor 180, temperature sensors, fans, and any other component that may be electrically controlled. In some embodiments, a separate processor (and/or memory) may be coupled to one or more of the components.
Controller 400 is programmed to operate oxygen concentrator system 100 and is further programmed to monitor the oxygen concentrator system for malfunction states. For example, in one embodiment, controller 400 is programmed to trigger an alarm if the system is operating and no breathing is detected by the user for a predetermined amount of time. For example, if controller 400 does not detect a breath for a period of 75 seconds, an alarm LED may be lit and/or an audible alarm may be sounded. If the user has truly stopped breathing, for example, during a sleep apnea episode, the alarm may be sufficient to awaken the user, causing the user to resume breathing. The action of breathing may be sufficient for controller 400 to reset this alarm function. Alternatively, if the system is accidently left on when output conduit 192 is removed from the user, the alarm may serve as a reminder for the user to turn oxygen concentrator system 100 off.
Controller 400 is further coupled to oxygen sensor 165, and may be programmed for continuous or periodic monitoring of the oxygen concentration of the oxygen enriched gas passing through expansion chamber 170. A minimum oxygen concentration threshold may be programmed into controller 400, such that the controller lights an LED visual alarm and/or an audible alarm to warn the patient of the low concentration of oxygen.
Controller 400 is also coupled to internal power supply 180 and is capable of monitoring the level of charge of the internal power supply. A minimum voltage and/or current threshold may be programmed into controller 400, such that the controller lights an LED visual alarm and/or an audible alarm to warn the patient of low power condition. The alarms may be activated intermittently and at an increasing frequency as the battery approaches zero usable charge.
Further functions of controller 400 are described in detail in other sections of this disclosure.
A user may have a low breathing rate or depth if relatively inactive (e.g., asleep, sitting, etc.) as assessed by comparing the detected breathing rate or depth to a threshold. The user may have a high breathing rate or depth if relatively active (e.g., walking, exercising, etc.). An active/sleep mode may be assessed automatically and/or the user may manually indicate a respective active or sleep mode by a pressing button for active mode and another button for sleep mode. In some embodiments, a user may toggle a switch from active mode, normal mode, or sedentary mode. The adjustments made by the oxygen concentrator system in response to activating active mode or sleep mode are described in more detail herein.
Methods of Delivery of Oxygen Enriched Gas
The main use of an oxygen concentrator system is to provide supplemental oxygen to a user. Generally, the amount of supplemental oxygen to be provided is assessed by a physician. Typical prescribed amounts of supplemental oxygen may range from about 1 LPM to up to about 10 LPM. The most commonly prescribed amounts are 1 LPM, 2 LPM, 3 LPM, and 4 LPM. Generally, oxygen enriched gas is provided to the use during a breathing cycle to meet the prescription requirement of the user. As used herein the term “breathing cycle” refers to an inhalation followed by an exhalation of a person.
In order to minimize the amount of oxygen enriched gas that is needed to be produced to meet the prescribed amounts, controller 400 may be programmed to time delivery of the oxygen enriched gas with the user's inhalations. Releasing the oxygen enriched gas to the user as the user inhales may prevent unnecessary oxygen generation (further reducing power requirements) by not releasing oxygen, for example, when the user is exhaling. Reducing the amount of oxygen required may effectively reduce the amount of air compressing needed for oxygen concentrator 100 (and subsequently may reduce the power demand from the compressors).
Oxygen enriched gas, produced by oxygen concentrator system 100 is stored in an oxygen accumulator 106 and released to the user as the user inhales. The amount of oxygen enriched gas provided by the oxygen concentrator system is controlled, in part, by supply valve 160. In an embodiment, supply valve 160 is opened for a sufficient amount of time to provide the appropriate amount of oxygen enriched gas, as assessed by controller 400, to the user. In order to minimize the amount of oxygen required to meet the prescription requirements of a user, the oxygen enriched gas may be provided in a bolus when a user's inhalation is first detected. For example, the bolus of oxygen enriched gas may be provided in the first few milliseconds of a user's inhalation.
In an embodiment, pressure sensor 194 and/or flow rate sensor 185 may be used to determine the onset of inhalation by the user. For example, the user's inhalation may be detected by using pressure sensor 194. In use, a conduit for providing oxygen enriched gas is coupled to a user's nose and/or mouth (e.g., using a nasal cannula or a face mask). At the onset of an inhalation, the user begins to draw air into their body through the nose and/or mouth. As the air is drawn in, a negative pressure is generated at the end of the conduit, due, in part, to the venturi action of the air being drawn across the end of the delivery conduit. Pressure sensor 194 may be operable to create a signal when a drop in pressure is detected, to signal the onset of inhalation. Upon detection of the onset of inhalation, supply valve 160 is controlled to release a bolus of oxygen enriched gas from the accumulator 106.
In some embodiments, pressure sensor 194 may provide a signal that is proportional to the amount of positive or negative pressure applied to a sensing surface. The amount of the pressure change detected by pressure sensor 194 may be used to refine the amount of oxygen enriched gas being provided to the user. For example, if a large negative pressure change is detected by pressure sensor 194, the volume of oxygen enriched gas provided to the user may be increased to take into account the increased volume of gas being inhaled by the user. If a smaller negative pressure is detected, the volume of oxygen enriched gas provided to the user may be decreased to take into account the decreased volume of gas being inhaled by the user. A positive change in the pressure indicates an exhalation by the user and is generally a time that release of oxygen enriched gas is discontinued. Generally while a positive pressure change is sensed, valve 160 remains closed until the next onset of inhalation.
In some embodiments, the sensitivity of the pressure sensor 194 may be affected by the physical distance of the pressure sensor 194 from the user, especially if the pressure sensor is located in oxygen concentrator system 100 and the pressure difference is detected through the tubing coupling the oxygen concentrator system to the user. In some embodiments, the pressure sensor may be placed in the airway delivery device used to provide the oxygen enriched gas to the user. A signal from the pressure sensor may be provided to controller 400 in the oxygen concentrator 100 electronically via a wire or through telemetry such as through BLUETOOTH® (Bluetooth, SIG, Inc. Kirkland, Wash.) or other wireless technology.
In an embodiment, the user's inhalation may be detected by using flow rate sensor 185. In use, a conduit for providing oxygen enriched gas is coupled to a user's nose and/or mouth (e.g., using a nasal cannula or face mask). At the onset of an inhalation, the user begins to draw air into their body through the nose and/or mouth. As the air is drawn in, an increase in flow of gas passing through conduit is created. Flow rate sensor 185 may be operable to create a signal when an increase in flow rate is detected, to signal the onset of inhalation. Upon detection of the onset of inhalation, supply valve 160 is controlled to release a bolus of oxygen enriched gas from the accumulator 106.
A user breathing at a rate of 30 breaths per minute (BPM) during an active state (e.g., walking, exercising, etc.) may consume two and one-half times as much oxygen as a user who is breathing at 12 BPM during a sedentary state (e.g., asleep, sitting, etc.). Pressure sensor 194 and/or flow rate sensor 185 may be used to determine the breathing rate of the user. Controller 400 may process information received from pressure sensor 194 and/or flow rate sensor 185 and determine a breathing rate based on the frequency of the onset of inhalation. The detected breathing rate of the user may be used to adjust the bolus of oxygen enriched gas. The volume of the bolus of oxygen enriched gas may be increased as the users breathing rate increase, and may be decreased as the users breathing rate decreases. Controller 400 may automatically adjust the bolus based on the detected activity state of the user. Alternatively, the user may manually indicate a respective active or sedentary mode by selecting the appropriate option on the control panel of the oxygen concentrator. Alternatively, a user may operate controller 400 from a remote electronic device. For example, a user may operate the controller using a smart phone or tablet device.
In some embodiments, if the user's current activity level as assessed using the detected user's breathing rate exceeds a predetermined threshold, controller 400 may implement an alarm (e.g., visual and/or audio) to warn the user that the current breathing rate is exceeding the delivery capacity of the oxygen concentrator system. For example, the threshold may be set at 20 breaths per minute.
In some embodiments, controller 400 may operate the oxygen concentrator based on the change in the inspiration breath pressure threshold. The frequency and/or duration of the provided oxygen enriched gas to the user relative to the current frequency and/or duration may be adjusted based on the change in the inspiration breath pressure threshold. Upon determining that the inspiration breath pressure threshold has been lowered, the controller 400 may switch the oxygen concentrator to a sedentary mode. Controller 400 may switch the oxygen concentrator to an active mode, when the inspiration breath pressure threshold has been raised.
In some embodiments, as seen in
In some embodiments, the sensitivity of the oxygen concentrator 100 may be selectively attenuated to reduce false inhalation detections due to movement of air from a different source (e.g., movement of ambient air). For example, the oxygen concentrator 100 may have two selectable modes—an active mode and an inactive mode. In some embodiments, the user may manually select a mode (e.g., through a switch or user interface). In some embodiments, the mode may be automatically selected by the oxygen concentrator 100 based on a detected breathing rate. For example, the oxygen concentrator 100 may use the pressure sensor 194 to detect a breathing rate of the user. If the breathing rate is above a threshold, the oxygen concentrator 100 may operate in an active mode (otherwise, the oxygen concentrator may operate in an inactive mode). Other modes and thresholds are also contemplated.
In some embodiments, in active mode, the sensitivity of the pressure sensor 194 may be mechanically, electronically, or programmatically attenuated. For example, during active mode, controller 400 may look for a greater pressure difference to indicate the start of a user breath (e.g., an elevated threshold may be compared to the detected pressure difference to determine if the bolus of oxygen should be released). In some embodiments, the pressure sensor 194 may be mechanically altered to be less sensitive to pressure differences. In some embodiments, an electronic signal from the pressure sensor may be electronically altered to ignore small pressure differences. This can be useful when in active mode. In some embodiments, during the inactive mode the sensitivity of the pressure sensor may be increased. For example, the controller 400 may look for a smaller pressure difference to indicate the start of a user breath (e.g., a smaller threshold may be compared to the detected pressure difference to determine if the bolus of oxygen should be released). In some embodiments, with increased sensitivity, the response time for providing the bolus of oxygen during the user's inhalation may be reduced. The increased sensitivity and smaller response time may reduce the size of the bolus necessary for a given flow rate equivalence. The reduced bolus size may also reduce the size and power consumption of the oxygen concentrator 100.
Providing a Bolus Based on Inhalation Profile
In an embodiment, the bolus profile can be designed to match the profile of a particular user. To do so, an inhalation profile may be generated based on information gathered from pressure sensor 194 and flow rate sensor 185. An inhalation profile is assessed based on, one or more of the following parameters: the breathing rate of the user; the inhalation volume of the user; the exhalation volume of the user; the inhalation flow rate of the user; and the exhalation flow rate of the user. The breathing rate of the user may be assessed by detecting the onset of inhalation using pressure sensor 194 or flow rate sensor 185 as previously discussed. Inhalation volume may be assessed by measuring the change in pressure during inhalation and calculating or empirically assessing the inhalation volume based on the change in pressure. Alternatively, inhalation volume may be assessed by measuring the flow rate during inhalation and calculating or empirically assessing the inhalation volume based on the flow rate and the length of the inhalation. Exhalation volume may be assessed in a similar manner using either positive pressure changes during exhalation, or flow rate and exhalation time. Inhalation flow rate of the user is measured from shortly after the onset of inhalation. Detection of the end of inhalation may be from the pressure sensor or the flow rate sensor. When onset of inhalation is detected by the pressure sensor, the onset is characterized by a drop in pressure. When the pressure begins to increase, the inhalation is considered complete. When onset of inhalation is detected by the flow rate sensor, the onset is characterized by an increase in the flow rate. When the flow rate begins to decrease, the inhalation is considered complete.
There is a minimum amount of oxygen necessary for a person to remain conscious. A person who is breathing rapidly is bringing in a lower volume of air in each breath, and thus, requires less oxygen enriched gas per inhalation. While there is some variation from patient to patient, this relationship can be used to establish the mean flow rate for each breath mathematically. By measuring a large population of patients, the profile of the relative flow from onset of inhalation to the onset of exhalation may be established. Using this flow profile as a template, the calculated actual flow based on breathing rate can be adjusted mathematically to a calculated actual flow profile. This profile can be used to adjust the opening and closing of the delivery valve to create an idealized profile for the patient based on their breathing rate. Inhalation profile data gathered from a population of users may be used to create an algorithm that makes the appropriate adjustments based on the detected inhalation profile. Alternatively, a look up table may be used to control valve actuation durations and pulse quantities based on a detected inhalation profile.
Measuring the inhalation profile of the patient provides a more accurate basis for control of the bolus of oxygen enriched gas being provided to the patient. For example, basing the delivery of oxygen enriched gas on the onset of inhalation may not take into account differences between individual users. For example, people having a similar breathing rate can have different inhalation/exhalation volume, inhalation/exhalation flow rates and, thus, different bolus requirements necessary to produce the prescribed amount of oxygen. In one embodiment, an inhalation profile is created based on the flow rate of air during inhalation and the duration of inhalation. The inhalation profile can then be used as a predictor of the volume of air taken in by a specific user during inhalation. Thus, inhalation profile information can be used to modify the amount of oxygen enriched air provided to the user to ensure that the prescribed level of oxygen is received. The amount of oxygen provided to a user may be adjusted by modifying the frequency and or duration of release of oxygen enriched gas from the accumulator with supply valve 160. By tracking the inhalation profile of the patient controller adjusts the delivery supply valve actuation to idealize the bolus profile to provide the oxygen at the maximum rate without causing wasteful retrograde flow.
Power Management
Power for operation of oxygen concentrator system is provided by an internal power supply 180. Having an internal power supply allows portable use of the oxygen concentrator system. In one embodiment, internal power supply 180 includes a lithium ion battery. Lithium ion batteries offer advantages over other rechargeable batteries by being able to provide more power by weight than many other batteries.
In one embodiment, the compression system, valves, cooling fans and controller may all be powered by an internal power supply. Controller 400 (depicted schematically in
In one embodiment, controller 400 adjusts the operation of one or more compressors (for example, compressor 210) based on the oxygen output needs of the user. Controller 400 may assess a preselected prescription for the oxygen concentrator. In the embodiments shown herein, the oxygen concentrator has a switch which is set by the user or the prescribing doctor at the proper prescription rate (1 LPM up to 5 LPM). Controller 400 can assess the position of the switch to determine the prescription for the subject. Based on the prescription of the subject, the controller causes one or more of the compressors to operate to begin production of oxygen.
In many instances, the operation energy of the oxygen concentrator can be optimized by operating the compressors at less than their normal maximum compressor speed. As used herein, the phrase “normal maximum compressor speed” means the speed that the compressor runs when the compressor is supplied with a current and voltage to the drive transmission system that corresponds with the manufacturer's highest listed current and voltage for proper operation of the compressor.
At low prescription rates (e.g., 1 LPM) it may not be necessary to run both compressors to produce enough oxygen for the user. In some instances, it may not be necessary to run the compressor(s) at the normal maximum compressor speed. Controller 400 may be programmed to control the operation of one or more compressors at a percentage of the normal maximum compressor speed, wherein the percentage is assessed based on the preselected prescription. In some instance, the selected percentage is percentage less than 100%. If the prescription setting for the oxygen concentrator is changed, controller 400 may adjust the compressor speed to a different percentage of the normal maximum compressor speed based on changes in the prescription and/or the breathing rate of the user.
Controller 400 may further assess the breathing rate of the subject. When providing oxygen to the user, the amount of oxygen needed to maintain the proper prescription is based on the breathing rate of the user. When the user has a low breathing rate (e.g., 15 breaths per minute (“bpm”) or less) then the compressor may operate at a first percentage of the normal maximum compressor speed. If the users breathing rate increases, it may be necessary for the compressor to be operated at a second percentage of the normal maximum compressor speed, which is different from the first percentage. In this situation the second percentage will be a higher percentage than the first percentage.
When only one compressor is being used, the controller may arbitrarily select which compressor is operated. The selection of the compressor may be randomized or alternated, to avoid using one compressor more than the other compressor(s). This will help extend the life of the compressors.
At high prescriptions, (e.g., 3 LPM or more) it may be necessary to run more than one compressor at the same time to provide sufficient oxygen for the user. When two or more compressors are operated at the same time, each of the compressors may be operated at a percentage less than the normal maximum compressor speed. If the breathing rate of the user increases, the speed of each compressor may also be increased. In some embodiments, the compressors may not be capable of moving enough air to produce sufficient oxygen for the patient when operating at 100% of the normal maximum compressor speed. Controller 400 may be capable of sending a voltage and or current to one or more of the compressors that is above the manufacturer's highest listed current and voltage for proper operation of the compressor. This will cause the compressor(s) to run at a speed above the normal maximum compressor speed. This allows the controller to maintain proper oxygen delivery to the patient, even when the patient's oxygen needs exceed the normal operating parameters of the oxygen concentrator.
In some embodiments, only one compressor may be used to produce the oxygen needed by the patient. The compressor may be operated at a speed that is less than the normal maximum compressor speed. If the activity level of the patient increases the controller may increase the speed of the compressor to increase the production of oxygen. As the speed of the compressor approaches 100% of the normal maximum compressor speed, the controller may start a second compressor before the first compressor reaches 100% of the normal maximum compressor speed. Both compressors may be operated at the same speed, or different speeds. Both compressors may be operated at a speed that is less than the normal maximum compressor speed. The first compressor and the second compressor may be operated at the same percentage of the normal compressor speed.
In an exemplary embodiment, an oxygen concentrator has two compressors. At a prescription of 1 LPM, a single compressor is operated at about 65% of the normal maximum compressor speed to provide oxygen to the user, if the breathing rate is at about 12-15 bpm. The compressor that is operated is arbitrarily selected by the controller. If the breathing rate of the subject increases above 15 bpm, the compressor speed may be increased to compensate for the increased breathing rate. In this example, the compressor speed remains below 100% of the normal maximum compressor speed at any given breathing rate.
In the same exemplary system, if the prescription is increased to 2 LPM, a single compressor is operated at about 75% of the normal maximum compressor speed, to provide oxygen to the user, if the breathing rate is at about 12-15 bpm. If the breathing rate of the user increases above 15 bpm, the compressor speed is increased up until the speed of the compressor reaches 85% of the normal maximum compressor speed. At this point the controller turns on the second compressor, and adjust the speed of both compressors, so that both compressors operate at about 65% of the normal maximum compressor speed.
In the same exemplary system, if the prescription is increased to 3 LPM, both compressors are operated at about 85% of the normal maximum compressor speed, to provide oxygen to the user, if the breathing rate is at about 12-15 bpm. If the breathing rate of the user increases above 15 bpm, the speed of both compressors is increased. If the breathing rate approaches 25 bpm, the compressors may not be able to provide sufficient oxygen when operated at the normal maximum compressor speed. To provide the proper amount of oxygen to the patient, each compressor may be operated at a speed that is greater than the normal maximum compressor speed. Since breathing rates at or above 25 bpm are typically not maintained for long periods of time by the user, the overdriving of the compressors is typically not performed for long.
This method of controlling the compressors was shown to improve the battery life of the oxygen concentrator. In a prior set up, when the compressors were operated at a single speed, the battery life for the oxygen concentrator was about 2 hours. When the same system was updated using the control method described above, the battery life was increased to 9 hours.
Canisters
When using a gas separation adsorbent, oxygen is separated from air by adsorption of molecules other than oxygen onto the gas separation adsorbent. The adsorption process may be enhanced by the choice of the gas separation adsorbent and/or by the design of the canister that contains the gas separation adsorbent. Oxygen concentrator apparatus 100 may include canisters containing gas separation adsorbent that are designed to produce a steady gas flow (laminar gas flow) or substantially steady gas flow. The canister may be an elongated tube (for example, cylindrical) with a diameter of a first end of the canister being larger than the diameter of the second end of the canister. For example, the canister may be tapered outwardly at the exit end of the canister. Such a canister design, when filled with gas separation adsorbent (for example, zeolite), may produce a gas flow having a Reynolds number ranging from about 10 to about 20 or from about 10 to about 18.
In some embodiments, the canister may include baffles. One or more baffles may be positioned along the inner wall of the canister at a desired angle relative to the side wall. For example, the baffles may be at about a 90 degree angle relative to the side wall.
In some embodiments, a canister is made from one or more polymers, one or more nonmetals, one or more metal compounds, or mixtures thereof. Examples of polymers include thermosetting polymers, thermoplastic polymers, polyamides, polyesters, polycarbonates, and the like. Examples, of nonmetals include, glass, fused silica, glass fiber, or the like. Examples of metal compounds include aluminum, nickel, copper, metal alloys, or the like. In some embodiments, a canister may be made from polyamides, glass fiber, aluminum or mixtures thereof. For example, the canister may be made of about 60% polyamide and about 40% glass, about 70% polyamide and about 40% glass, or about 80% polyamide and about 20% glass. The canister may include a thin coating of a metal or metal alloy on the inner and/or outer surface of the canister. Films may be deposited on the surface of the canister using physical vapor deposition methods or other methods known in the art to deposit films. An example of physical vapor deposition is sputtering. Using a thin coat of metal or metal alloy may allow fabrication of a light weight canister that does not collapse under pressure. In some embodiments, the canisters are manufactured from materials that all the canister to be disposable.
Ionized Air
Due to the size of the canister in the oxygen concentrator, the quantity of gas separation adsorbent is small, but is capable of producing an adequate quantity of product gas. Since the gas separation adsorbent is optimized for maximum performance for a specific oxygen concentrator (for example, the canister), any significant decrease in capacity of the gas separation adsorbent over time results in decreased product purity. One contributing factor that may lead to a decrease in bed capacity is the adsorption of impurities that do not completely desorb during normal process operation, leading to the accumulation and retention of impurities in the gas separation adsorbent. An example of such an impurity that reduces the adsorption capacity of many zeolites used in air separation is water.
Some stationary concentrators utilize some means of removing water from the compressed gas before feeding the gas separation adsorbent. Portable concentrators, by the nature of their application, are more likely to be exposed to a wide range of operating conditions including high humidity environments and/or rapid temperature changes that could result in the need for more sophisticated water rejection capabilities than implemented in conventional portable oxygen concentrators. If water is present, either in the form of liquid or vapor, and enters the gas separation adsorbent, the gas adsorbent may adsorb at least some of the water during each adsorption cycle.
When zeolites are used as the gas separation adsorbent, the energy of adsorption of water is high relative to other types of adsorbent. During the gas separation process not all adsorbed water may be desorbed during evacuation/purge of the beds under typical cycling. Therefore, complete removal of adsorbed water from gas separation adsorbent usually entails applying some sort of energy to the beds, such as thermal, infrared, or microwave, and purging with a dry gas or applying a vacuum to the beds during the regeneration process.
Although highly effective air drying systems exist in other types of gas separation adsorbent fields, most of these systems consume power, increase size and weight, or reduce system efficiency in a manner detrimental to the stringent power consumption, size/weight, and acoustic noise level requirements of portable concentrators. Using a single process gas separation adsorbent with some portion of the gas separation adsorbent dedicated to impurity processing/rejection is a common method of adding impurity rejection to a gas separation system. Adding canisters containing gas separation adsorbent dedicated to dehydration of the feed stream upstream of the gas separation adsorbent or implementing layered absorbent utilizing desiccants in addition to gas adsorbent suited for the desired gas fractionation are also common methods of adding water rejection capacity to a gas separation system, and can be effective in many circumstances. However, additional canisters add significant size and weight to the concentrator, or in the case of layered absorbents, the desiccant layer displaces volume that could otherwise be used for adsorbent used for highly efficient air separation or the volume of the process columns could be decreased accordingly, and additional power is used to compress gas through the desiccant.
Desiccants typically used for pre-drying air are also prone to deactivation during constant cycling as well as during shutdown periods, and are often regenerated via applying one of the aforementioned methods. In some cases, the desiccant layer may be advantageous, but also might not be entirely effective at protecting the specialized adsorbents from water damage. By their nature, personal oxygen concentrators, be they portable or stationary, often operate in varied usage modalities rather than in the continuous duty manner of an industrial gas production plant. The duty cycle, storage time between use, and storage environment, can vary widely from unit to unit. For example, home health care providers may have a fleet of units that are stored in warehouses that are not climate controlled while waiting for delivery to patients for use. Similarly, patients may store units in their car or home for a given period of time without use depending on their individual oxygen needs. Thus, care must be used in shutting down and storing units containing gas separation adsorbent that are run on an intermittent basis. Any water (or other impurities) remaining in the desiccant layer(s) or portion of the gas separation adsorbent used for feed gas drying upon shutdown will diffuse over time due to the gradient in chemical potential between the portion of the bed that is used for impurity removal during normal operation and the dry portion of the beds.
The diffusion coefficient of water in zeolites has Arrhenius type temperature dependence, so if a concentrator is stored in a high temperature environment the rate of intraparticle diffusion will increase exponentially with temperature. The gas phase diffusion rate will increase with increasing temperature as well. Thus, in an oxygen concentrator system it is advantageous to remove as much water as possible from the compressed gas feed stream to prevent deactivation of the highly efficient zeolite, use less desiccant, and minimize the presence of water in the gas separation adsorbent during shutdown. Traditional means of removing water such as coalescing filters and gravity water traps have limited abilities to remove water and can thereby limit the usable service life of oxygen concentrating equipment. The varying operating and storage environments that portable concentrators may be exposed to result in design challenges that more conventional gas separation systems such as gas separation plants might not encounter and must be addressed. As described, more efficient removal of water and/or other impurities from gas separation adsorbent is desired.
Gas separation adsorbent (for example, zeolites) may have two or more layers that include charged layers. A first layer may include positively charged particles, and a second layer may include negatively charged particles dispersed on top of the negatively charged particles, or vise versa. The negatively charged particles may be evenly or unevenly dispersed on the first layer. For example, water molecules may be electrostatically bound to protons or metal cations in the zeolite. Applying current to the gas separation adsorbent or providing charged air to the gas separation adsorbent may change or disturb the electrostatic charge. For example, the Gouy-Chapman model of electrical double layer may be applied to the canisters. Disruption of the electrostatic charge may release the water from the gas separation adsorbent. The water may be vented from the canister. Removal of a sufficient amount of water may recharge the gas separation adsorbent. Thus, the gas separation adsorbent may be reused. Such treatment of a gas separation adsorbent may extend the life of the gas separation adsorbent and provide economical gas separation adsorbents with good reliability.
In some embodiments, oxygen concentrator apparatus 100 may include a canister containing gas separation adsorbent, at least two electrodes and a power supply.
Electrodes 610, 610′ may be flat, cylindrical or any suitable shape. As shown in
In some embodiments, electrodes 610, 610′ are removably coupled to the canister. Using electrodes 610, 610′ (and electrode power supply) that are removably coupled to the canister allows the electrodes to be removed after the gas separation adsorbent is recharged. Thus, the extra weight of the power supply and/or electrodes is not added to the weight of the portable oxygen concentrator.
Supply of power to one of the electrodes, electrically excites the electrode such that current flows between the two electrodes. The current may ionize air flowing between the two electrodes. The ionized air may contact the gas separation adsorbent and ionize water absorbed in the gas separation adsorbent. In some embodiments, contact of the ionized air with bacteria absorbed on the gas separation adsorbent may kill some or all of the bacteria present. In some embodiments, current flowing between electrodes 610, 610′ may produce sufficient heat to desorb water from the gas separation adsorbent and/or kill bacteria in the gas separation adsorbent. Removal of water and/or bacteria from the gas separation adsorbent may sufficiently recharge the gas separation adsorbent for continued use.
Thermal Shutdown
During use of an oxygen concentrator system, there are many sources of heat that may cause the temperature of the unit to become elevated. As the temperature of the oxygen concentrator system increases, the components will begin to operate less efficiently. Eventually, if the oxygen concentrator system becomes too hot, some components may become permanently damage, requiring extensive repairs to place the system back into service. In one embodiment, one or more temperature sensors are placed within the body of an oxygen concentrator system. Temperature sensors may be coupled to a controller of the oxygen concentrator system which monitors the internal temperature of the system. If the sensed internal temperature of the oxygen concentrator system exceeds a predetermined threshold, the controller may provide signals that cause the system to shut down until the temperature of the system drops below a predetermined temperature. For example, a controller may initiate a shutdown sequence if the internal temperature of an oxygen concentrator system exceeds 60° C. The oxygen concentrator system may be kept in a shutdown state until the internal temperature of the system falls below 55° C.
Autopulse Diagnostic Mode
For diagnostic purposes, it may be desirable to check the operation of an oxygen concentrator system by triggering release of the oxygen enriched gas produced by the system. During normal operation, the release of oxygen enriched gas is triggered by a sensed inhalation by the user. For diagnostic testing, it is desirable to be able to trigger the release of oxygen enriched gas produced by an oxygen concentrator system, to test for purity and accuracy of the volume of gas released. In one embodiment, an autopulse mode may be programmed into a controller of an oxygen concentrator system. Autopulse mode may be used to release oxygen enriched gas produced by the oxygen concentrator system without the need to detect an inhalation of a user. In autopulse mode, the controller may provide signals to oxygen concentrator system to release oxygen enriched gas according to predetermined rates. For example, in autopulse mode, the controller may produce pulses of oxygen enriched gas corresponding to breathing rates of 10 bpm, 15 bpm, 20 bpm, 25 bpm, and 30 bpm. Other breathing rates may also be simulated in autopulse mode. In this manner, the operation of the components may be assessed to see if the device is functionally properly.
Off-Time
When a portable oxygen concentrator, stationary oxygen concentrator, or a hybrid oxygen concentrator is not being used (for example, when the unit is turned off, being shipped, stored, or the like), the gas separation adsorbent may be detrimentally effected and/or deactivated, and thus, the life of the device (gas separation adsorbent) may be effected. For example, when the oxygen concentrator is turned off, pressure in the canister is released. Wet air may be drawn into the canister and be absorbed by the gas separation adsorbent. For example, a device may lose up to 50% of the mean time between failure when the machine is turned off for an extended period of time. Conditioning the device and/or gas separation adsorbent when the oxygen concentrator is in “off time” may extend the life of the device. In some embodiments, the canisters containing gas separation adsorbent may conditioned by storing the gas separation adsorbent or the canister containing the gas separation adsorbent under pressure. For example, the canisters may be pressurized at stored at a pressure ranging from about 5 psi to above 10 psi.
The controller may monitor and/or assess the pressure of the oxygen concentrator canisters when the canisters are not being used. In a hybrid system, the controller may monitor and determine the pressure of the stationary oxygen concentrator system canisters while the portable oxygen concentrator is being used or vice versa. When the pressure drops below a specified pressure (for example, below 10 psi, below 8 psi, or below 5 psi), the controller will start the compression system (wake-up the machine), and pressurize the canister to the desired pressure. In some embodiments, the canister is pressurized by providing compressed air that has been passed through an adsorbent that dries the water from the air prior to entering the canister. After the canister is pressurized to the desired pressure, the controller will turn the oxygen concentrator off.
In some embodiments, program instructions in processor 420 of controller 400 are operable to perform various predefined methods that are used to monitor the pressure of the oxygen concentrator when the oxygen concentrator is in an off state. The controller may automatically assess a state of the oxygen concentrator. For example, the state of the oxygen concentrator may be off or on. Based on the assessed state, the controller may assess a pressure of one or more of the canister. The current pressure of the canister may be stored in memory. The assessed pressure may be determined to be low or normal. For example, the assessed pressure may be compared to a defined pressure range. The defined pressure range may be in a look-up table. In some embodiments, a low or normal pressure is determined using an algorithm.
When the pressure is determined to be low, the controller turns on the compression system and the canister is pressurized to the desired pressure. The speed of the compressor may be adjusted based on the desired pressure and/or the assessed pressure. The controller may continue to monitor the pressure of the canister and when the canister pressure is at the desired pressure, the compression system is turn off. Such monitoring of the canister pressures and pressurizing the canisters as needed during an off time extends the life of the gas separation adsorbent.
Adsorbent Life Compensation
In some embodiments, the life of the gas separation adsorbent may be extended by adjusting the operation of the compressor. During use, the gas separation adsorbent of an oxygen concentrator system will acquire moisture from the air that is contacted with the adsorbent. The moisture in the air reduces the amount of nitrogen that the gas separation adsorbent can remove from the air. When the unit no longer produces oxygen enriched gas having a purity above 85%, the gas separation adsorbent typically needs to be replaced. In an embodiment, a controller of an oxygen concentrator system monitors the oxygen purity and, as it becomes lowers over time, the compressor system is adjusted to provide higher pressure compressed air to the canisters. Generally, gas separation adsorbents will adsorb more nitrogen as the pressure inside the canisters is increased. By operating the compressors at a faster speed, the pressure inside the canisters will increase, leading to higher purity oxygen enriched gas. Operating the compressors at a higher speed will reduce the run time of a battery powered oxygen concentration system, but will allow the user to extend the life of the gas separation adsorbent until the adsorbent is replaced. Oxygen sensors (previously described) are used to assess the purity of the oxygen enriched gas and a controller may alter the operating speed of the compressors to extend the useable life of the gas separation adsorbent.
In this patent, certain U.S. patents, U.S. patent applications, and other materials (e.g., articles) have been incorporated by reference. The text of such U.S. patents, U.S. patent applications, and other materials is, however, only incorporated by reference to the extent that no conflict exists between such text and the other statements and drawings set forth herein. In the event of such conflict, then any such conflicting text in such incorporated by reference U.S. patents, U.S. patent applications, and other materials is specifically not incorporated by reference in this patent.
Further modifications and alternative embodiments of various aspects of the invention may be apparent to those skilled in the art in view of this description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims.
This application claims priority to U.S. Provisional Application Ser. No. 61/940,046 entitled “OXYGEN CONCENTRATOR SYSTEMS AND METHODS” filed Feb. 14, 2014, which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3602617 | Takahashi | Aug 1971 | A |
| 3768468 | Cox | Oct 1973 | A |
| 4194890 | McCombs et al. | Mar 1980 | A |
| 4215798 | Acharya | Aug 1980 | A |
| 4302224 | McCombs et al. | Nov 1981 | A |
| 4331455 | Sato | May 1982 | A |
| 4342573 | McCombs et al. | Aug 1982 | A |
| 4349357 | Russell | Sep 1982 | A |
| 4491459 | Pinkerton | Jan 1985 | A |
| 4519387 | Durkan et al. | May 1985 | A |
| 4550276 | Callahan et al. | Oct 1985 | A |
| 4576616 | Mottram et al. | Mar 1986 | A |
| 4612928 | Tiep et al. | Sep 1986 | A |
| 4630482 | Traina | Dec 1986 | A |
| 4681099 | Sato et al. | Jul 1987 | A |
| 4698075 | Dechene | Oct 1987 | A |
| 4747762 | Fairbairn | May 1988 | A |
| 4813979 | Miller et al. | Mar 1989 | A |
| 4857086 | Kawai | Aug 1989 | A |
| 4859217 | Chao | Aug 1989 | A |
| 4892566 | Bansal et al. | Jan 1990 | A |
| 4925464 | Rabenau et al. | May 1990 | A |
| 4927434 | Cordes et al. | May 1990 | A |
| 4938066 | Dorr | Jul 1990 | A |
| 4938212 | Snook et al. | Jul 1990 | A |
| 4968329 | Keefer | Nov 1990 | A |
| 4971049 | Rotariu et al. | Nov 1990 | A |
| 4971609 | Pawlos | Nov 1990 | A |
| 4973339 | Bansal | Nov 1990 | A |
| 4986269 | Hakkinen | Jan 1991 | A |
| 5004485 | Hamlin et al. | Apr 1991 | A |
| 5005571 | Dietz | Apr 1991 | A |
| 5024219 | Dietz | Jun 1991 | A |
| 5048515 | Sanso | Sep 1991 | A |
| 5052400 | Dietz | Oct 1991 | A |
| 5060506 | Douglas | Oct 1991 | A |
| 5060514 | Aylsworth | Oct 1991 | A |
| 5069688 | Wells | Dec 1991 | A |
| 5082473 | Keefer | Jan 1992 | A |
| 5099193 | Moseley et al. | Mar 1992 | A |
| 5099837 | Russel et al. | Mar 1992 | A |
| 5108467 | Schroter et al. | Apr 1992 | A |
| 5129924 | Schultz | Jul 1992 | A |
| 5146918 | Kallok et al. | Sep 1992 | A |
| 5176721 | Hay et al. | Jan 1993 | A |
| 5223004 | Eteve et al. | Jun 1993 | A |
| 5226933 | Knaebel et al. | Jul 1993 | A |
| 5268021 | Hill et al. | Dec 1993 | A |
| 5275642 | Bassine | Jan 1994 | A |
| 5315990 | Mondry | May 1994 | A |
| 5340381 | Vorih | Aug 1994 | A |
| 5351522 | Lura | Oct 1994 | A |
| 5378345 | Taylor et al. | Jan 1995 | A |
| 5469372 | McBrearty et al. | Nov 1995 | A |
| 5470378 | Kandybin et al. | Nov 1995 | A |
| 5474595 | McCombs | Dec 1995 | A |
| 5503146 | Froehlich et al. | Apr 1996 | A |
| 5549720 | Miller et al. | Aug 1996 | A |
| 5575282 | Knoch et al. | Nov 1996 | A |
| 5578115 | Cole | Nov 1996 | A |
| 5593478 | Hill et al. | Jan 1997 | A |
| 5603315 | Sasso | Feb 1997 | A |
| 5672195 | Moreau et al. | Sep 1997 | A |
| 5682877 | Mondry | Nov 1997 | A |
| 5690098 | Ottestad et al. | Nov 1997 | A |
| 5697364 | Chua et al. | Dec 1997 | A |
| 5730778 | Hill et al. | Mar 1998 | A |
| 5733359 | Doong et al. | Mar 1998 | A |
| 5735268 | Chua et al. | Apr 1998 | A |
| 5746806 | Aylsworth et al. | May 1998 | A |
| 5764534 | Goetting | Jun 1998 | A |
| 5766310 | Cramer | Jun 1998 | A |
| 5792665 | Morrow | Aug 1998 | A |
| 5827358 | Kulish et al. | Oct 1998 | A |
| 5839434 | Enterline | Nov 1998 | A |
| 5858062 | McCulloh et al. | Jan 1999 | A |
| 5858063 | Cao et al. | Jan 1999 | A |
| 5865174 | Kloeppel | Feb 1999 | A |
| 5890490 | Aylsworth et al. | Apr 1999 | A |
| 5893944 | Dong | Apr 1999 | A |
| 5906672 | Michaels et al. | May 1999 | A |
| 5913307 | Taieb et al. | Jun 1999 | A |
| 5917135 | Michaels et al. | Jun 1999 | A |
| 5922107 | Labasque et al. | Jul 1999 | A |
| 5928189 | Phillips et al. | Jul 1999 | A |
| 5957133 | Hart | Sep 1999 | A |
| 5961694 | Monereau et al. | Oct 1999 | A |
| 5968236 | Bassine | Oct 1999 | A |
| 5988465 | Vitale et al. | Nov 1999 | A |
| 5997617 | Czabala et al. | Dec 1999 | A |
| 6017315 | Starr et al. | Jan 2000 | A |
| 6030435 | Monereau et al. | Feb 2000 | A |
| 6056804 | Keefer | May 2000 | A |
| 6065473 | McCombs et al. | May 2000 | A |
| 6068680 | Kulish et al. | May 2000 | A |
| 6156101 | Naheiri | Dec 2000 | A |
| 6186142 | Schmidt et al. | Feb 2001 | B1 |
| 6186477 | McCombs et al. | Feb 2001 | B1 |
| 6192883 | Miller | Feb 2001 | B1 |
| 6220244 | McLaughlin | Apr 2001 | B1 |
| 6238458 | Monereau | May 2001 | B1 |
| 6253767 | Mantz | Jul 2001 | B1 |
| 6302107 | Richey et al. | Oct 2001 | B1 |
| 6314957 | Boissin et al. | Nov 2001 | B1 |
| 6342040 | Starr et al. | Jan 2002 | B1 |
| 6346139 | Czabala | Feb 2002 | B1 |
| 6371114 | Schmidt et al. | Apr 2002 | B1 |
| 6371117 | Lindqvist et al. | Apr 2002 | B1 |
| 6382931 | Czabala et al. | May 2002 | B1 |
| 6394089 | Cantrill et al. | May 2002 | B1 |
| 6395065 | Murdoch et al. | May 2002 | B1 |
| 6418782 | Sato et al. | Jul 2002 | B1 |
| 6427690 | McCombs et al. | Aug 2002 | B1 |
| 6446630 | Todd, Jr. | Sep 2002 | B1 |
| 6478850 | Warren | Nov 2002 | B1 |
| 6478857 | Czabala | Nov 2002 | B2 |
| 6484721 | Bliss | Nov 2002 | B1 |
| 6506234 | Ackley et al. | Jan 2003 | B1 |
| 6511526 | Jagger et al. | Jan 2003 | B2 |
| 6514318 | Keefer | Feb 2003 | B2 |
| 6520176 | Dubois et al. | Feb 2003 | B1 |
| 6527830 | Neu et al. | Mar 2003 | B1 |
| 6532958 | Buan et al. | Mar 2003 | B1 |
| 6536431 | Simler | Mar 2003 | B1 |
| 6547851 | Warren | Apr 2003 | B2 |
| 6551384 | Ackley et al. | Apr 2003 | B1 |
| 6558451 | McCombs et al. | May 2003 | B2 |
| 6561187 | Schmidt et al. | May 2003 | B2 |
| 6605136 | Graham et al. | Aug 2003 | B1 |
| 6629525 | Hill et al. | Oct 2003 | B2 |
| 6651658 | Hill et al. | Nov 2003 | B1 |
| 6655383 | Lundberg | Dec 2003 | B1 |
| 6669758 | Hart et al. | Dec 2003 | B1 |
| 6691702 | Appel et al. | Feb 2004 | B2 |
| 6694973 | Dunhao et al. | Feb 2004 | B1 |
| 6698423 | Honkonen et al. | Mar 2004 | B1 |
| 6699307 | Lomax | Mar 2004 | B1 |
| 6702880 | Roberts et al. | Mar 2004 | B2 |
| 6712876 | Cao et al. | Mar 2004 | B2 |
| 6712877 | Cao et al. | Mar 2004 | B2 |
| 6749405 | Bassine | Jun 2004 | B2 |
| 6755895 | Lomax et al. | Jun 2004 | B2 |
| 6764534 | McCombs et al. | Jul 2004 | B2 |
| 6790260 | Ackley et al. | Sep 2004 | B2 |
| 6802889 | Graham et al. | Oct 2004 | B2 |
| 6824590 | Dee et al. | Nov 2004 | B2 |
| 6827760 | Kutt et al. | Dec 2004 | B2 |
| 6837244 | Yagi et al. | Jan 2005 | B2 |
| 6866041 | Hardy et al. | Mar 2005 | B2 |
| 6866950 | Connor et al. | Mar 2005 | B2 |
| 6896721 | Lynn | May 2005 | B1 |
| 6908503 | McCombs et al. | Jun 2005 | B2 |
| 6918953 | Lomax et al. | Jul 2005 | B2 |
| 6929683 | Lomax et al. | Aug 2005 | B2 |
| 6935460 | McCombs et al. | Aug 2005 | B2 |
| 6935856 | Le Gouefflec | Aug 2005 | B2 |
| 6938619 | Hickle | Sep 2005 | B1 |
| 6949133 | McCombs et al. | Sep 2005 | B2 |
| 6981502 | McCormick et al. | Jan 2006 | B2 |
| 6990975 | Jones et al. | Jan 2006 | B1 |
| 7000612 | Jafari et al. | Feb 2006 | B2 |
| 7007694 | Aylsworth et al. | Mar 2006 | B2 |
| 7011092 | McCombs et al. | Mar 2006 | B2 |
| 7013898 | Rashad et al. | Mar 2006 | B2 |
| 7037358 | Babicki et al. | May 2006 | B2 |
| 7059323 | Kullik et al. | Jun 2006 | B2 |
| 7066985 | Deane et al. | Jun 2006 | B2 |
| 7077133 | Yagi et al. | Jul 2006 | B2 |
| 7105038 | Lee et al. | Sep 2006 | B2 |
| 7114932 | Bassine | Oct 2006 | B1 |
| 7121276 | Jagger et al. | Oct 2006 | B2 |
| 7122073 | Notaro et al. | Oct 2006 | B1 |
| 7135059 | Deane et al. | Nov 2006 | B2 |
| 7156903 | McCombs | Jan 2007 | B2 |
| 7171963 | Jagger et al. | Feb 2007 | B2 |
| 7178563 | Richey et al. | Feb 2007 | B2 |
| 7179326 | Nakamura et al. | Feb 2007 | B2 |
| 7204249 | Richey et al. | Apr 2007 | B1 |
| 7213468 | Fujimoto | May 2007 | B2 |
| 7222624 | Rashad et al. | May 2007 | B2 |
| 7225809 | Bowen et al. | Jun 2007 | B1 |
| 7279029 | Occhialini et al. | Oct 2007 | B2 |
| 7306657 | Yagi et al. | Dec 2007 | B2 |
| 7329304 | Bliss et al. | Feb 2008 | B2 |
| 7329354 | Mullee | Feb 2008 | B2 |
| 7396390 | Hayashi et al. | Jul 2008 | B2 |
| 7402193 | Bliss et al. | Jul 2008 | B2 |
| 7431032 | Jagger et al. | Oct 2008 | B2 |
| 7438745 | Deane et al. | Oct 2008 | B2 |
| 7473299 | Occhialini et al. | Jan 2009 | B2 |
| 7565907 | Curti et al. | Jul 2009 | B2 |
| 7582138 | Lessi et al. | Sep 2009 | B2 |
| 7585351 | Deane et al. | Sep 2009 | B2 |
| 7604004 | Jagger et al. | Oct 2009 | B2 |
| 7604005 | Jagger et al. | Oct 2009 | B2 |
| 7686870 | Deane et al. | Mar 2010 | B1 |
| 7708802 | Deane et al. | May 2010 | B1 |
| 7730887 | Deane et al. | Jun 2010 | B2 |
| 7753996 | Deane et al. | Jul 2010 | B1 |
| 7757693 | Toussaint | Jul 2010 | B2 |
| 7766010 | Jagger et al. | Aug 2010 | B2 |
| 7780768 | Taylor et al. | Aug 2010 | B2 |
| 7814906 | Moretti | Oct 2010 | B2 |
| 7837761 | Bliss et al. | Nov 2010 | B2 |
| 7841343 | Deane et al. | Nov 2010 | B2 |
| 7857894 | Taylor et al. | Dec 2010 | B2 |
| 7866315 | Jagger et al. | Jan 2011 | B2 |
| 7922789 | Deane et al. | Apr 2011 | B1 |
| 8016918 | LaBuda et al. | Sep 2011 | B2 |
| 8020558 | Christopher et al. | Sep 2011 | B2 |
| 8142544 | Taylor et al. | Mar 2012 | B2 |
| 8147597 | Dolensky et al. | Apr 2012 | B2 |
| 20010020603 | Moorehead et al. | Sep 2001 | A1 |
| 20030006024 | Wang | Jan 2003 | A1 |
| 20030111081 | Gupta | Jun 2003 | A1 |
| 20030140924 | Aylsworth et al. | Jul 2003 | A1 |
| 20040050255 | Simonds | Mar 2004 | A1 |
| 20040074496 | Hayashi et al. | Apr 2004 | A1 |
| 20040141874 | Mullinax | Jul 2004 | A1 |
| 20040159323 | Schmidt et al. | Aug 2004 | A1 |
| 20040182394 | Alvey et al. | Sep 2004 | A1 |
| 20050066976 | Wondka | Mar 2005 | A1 |
| 20050103341 | Deane et al. | May 2005 | A1 |
| 20050103343 | Gosweiler | May 2005 | A1 |
| 20050121033 | Starr et al. | Jun 2005 | A1 |
| 20050160905 | Whitley et al. | Jul 2005 | A1 |
| 20050192538 | Voege | Sep 2005 | A1 |
| 20050217674 | Burton et al. | Oct 2005 | A1 |
| 20060084877 | Ujhazy et al. | Apr 2006 | A1 |
| 20060102181 | McCombs et al. | May 2006 | A1 |
| 20060112962 | Tebbutt et al. | Jun 2006 | A1 |
| 20060117957 | McCombs | Jun 2006 | A1 |
| 20060144240 | Lee et al. | Jul 2006 | A1 |
| 20060174871 | Jagger | Aug 2006 | A1 |
| 20060174875 | Jagger et al. | Aug 2006 | A1 |
| 20060174876 | Jagger et al. | Aug 2006 | A1 |
| 20060174877 | Jagger et al. | Aug 2006 | A1 |
| 20060174880 | Jagger et al. | Aug 2006 | A1 |
| 20060174881 | Jagger et al. | Aug 2006 | A1 |
| 20060174882 | Jagger et al. | Aug 2006 | A1 |
| 20060185668 | Jagger et al. | Aug 2006 | A1 |
| 20060207594 | Stenzler et al. | Sep 2006 | A1 |
| 20060230931 | Bliss et al. | Oct 2006 | A1 |
| 20060230939 | Bliss et al. | Oct 2006 | A1 |
| 20060266357 | McCombs et al. | Nov 2006 | A1 |
| 20070039466 | Nawata et al. | Feb 2007 | A1 |
| 20070044799 | Hete et al. | Mar 2007 | A1 |
| 20070056583 | Jagger et al. | Mar 2007 | A1 |
| 20070056584 | Jagger et al. | Mar 2007 | A1 |
| 20070137487 | Whitley et al. | Jun 2007 | A1 |
| 20070169623 | Lee et al. | Jul 2007 | A1 |
| 20070227539 | Schwaibold et al. | Oct 2007 | A1 |
| 20070283958 | Naghavi | Dec 2007 | A1 |
| 20080053441 | Gottlib et al. | Mar 2008 | A1 |
| 20080066741 | Lemahieu et al. | Mar 2008 | A1 |
| 20080078392 | Pelletier et al. | Apr 2008 | A1 |
| 20080202508 | McClain et al. | Aug 2008 | A1 |
| 20080223367 | Cox et al. | Sep 2008 | A1 |
| 20080302364 | Garde et al. | Dec 2008 | A1 |
| 20090065007 | Wilkinson et al. | Mar 2009 | A1 |
| 20090065526 | Sprinkle | Mar 2009 | A1 |
| 20090107500 | Edwards | Apr 2009 | A1 |
| 20090107501 | Krieger | Apr 2009 | A1 |
| 20090133699 | Nalagatla et al. | May 2009 | A1 |
| 20090145428 | Sward et al. | Jun 2009 | A1 |
| 20090199855 | Davenport | Aug 2009 | A1 |
| 20090211438 | Thompson et al. | Aug 2009 | A1 |
| 20090211448 | McClain | Aug 2009 | A1 |
| 20090241956 | Baker et al. | Oct 2009 | A1 |
| 20090306529 | Curti et al. | Dec 2009 | A1 |
| 20100051030 | Richard et al. | Mar 2010 | A1 |
| 20100071698 | Kiritake | Mar 2010 | A1 |
| 20100094366 | McCarthy | Apr 2010 | A1 |
| 20100116270 | Edwards et al. | May 2010 | A1 |
| 20100133900 | King | Jun 2010 | A1 |
| 20100282084 | Taylor et al. | Nov 2010 | A1 |
| 20100313898 | Richard et al. | Dec 2010 | A1 |
| 20110017063 | Van Brunt et al. | Jan 2011 | A1 |
| 20110017216 | Van Brunt et al. | Jan 2011 | A1 |
| 20110020143 | Van Brunt et al. | Jan 2011 | A1 |
| 20110020156 | Van Brunt et al. | Jan 2011 | A1 |
| 20110030684 | Wilkinson et al. | Feb 2011 | A1 |
| 20110030685 | Wilkinson et al. | Feb 2011 | A1 |
| 20110030686 | Wilkinson et al. | Feb 2011 | A1 |
| 20110030687 | Wilkinson et al. | Feb 2011 | A1 |
| 20110030689 | Wilkinson et al. | Feb 2011 | A1 |
| 20110186054 | Boyd | Aug 2011 | A1 |
| 20110219948 | McCutchen | Sep 2011 | A1 |
| 20110232483 | Haberland et al. | Sep 2011 | A1 |
| 20110247620 | Armstrong et al. | Oct 2011 | A1 |
| 20110315140 | Shuman | Dec 2011 | A1 |
| 20120055340 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055474 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055475 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055477 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055478 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055480 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055482 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055483 | Wilkinson et al. | Mar 2012 | A1 |
| 20120167883 | Taylor et al. | Jul 2012 | A1 |
| 20120167886 | Taylor et al. | Jul 2012 | A1 |
| 20120167887 | Taylor et al. | Jul 2012 | A1 |
| 20120167888 | Taylor et al. | Jul 2012 | A1 |
| 20120266883 | Taylor et al. | Oct 2012 | A1 |
| 20130011292 | Simonds | Jan 2013 | A1 |
| 20140137737 | Wilkinson et al. | May 2014 | A1 |
| 20140137744 | Wilkinson et al. | May 2014 | A1 |
| 20140137859 | Wilkinson et al. | May 2014 | A1 |
| 20150059742 | Wilkinson et al. | Mar 2015 | A1 |
| Number | Date | Country |
|---|---|---|
| 0978477 | Feb 2000 | EP |
| 1205231 | May 2002 | EP |
| 1568391 | Aug 2005 | EP |
| 1661596 | May 2006 | EP |
| H07-172804 | Jul 1995 | JP |
| 2000354630 | Dec 2000 | JP |
| 2002253675 | Sep 2002 | JP |
| 2005087937 | Apr 2005 | JP |
| 2005245825 | Sep 2005 | JP |
| 2006095285 | Apr 2006 | JP |
| 2007195820 | Aug 2007 | JP |
| 4816590 | Nov 2011 | JP |
| 10-0741307 | Jul 2007 | KR |
| 9922795 | May 1995 | WO |
| 9943416 | Sep 1999 | WO |
| 0249742 | Jun 2002 | WO |
| 20060108092 | Oct 2006 | WO |
| Entry |
|---|
| Bonnema, Lisa. “Breathing Easy with Plastic Blends”; http://www.appliancemagazine. com/editorial.php?articl=927&zibe=211&first=1; issue: Apr. 2005 Appliance Magazine; downloaded on Jul. 26, 2007; 4 pages. |
| Freesyle; FreeStyleTM Portable Oxygen Concentrator, Patient Manual, AirSep, Revision; Jan. 27, 2006; 36 pages. |
| Lifestyle; Lifestyle TM Portable Oxygen Concentrator, Patient Manual, AirSep, Revision Date Dec. 2004; 40 pages. |
| Yang “Gas Separation by Adsorption Processes”, Imperial College Press, 1987, pp. 141-200. |
| Hartzog et al. “Sensitivity of PSA Process Performance to Input Variables”, Adsorption 1, 133-151 (1995). |
| Keller II et al., “A New Process for Adsorption Separation of Gas Streams”, ACS Symposium Series 135, 1980, pp. 275-286. |
| “Pressure Swing Adsorption” Douglas Morris Ruthven, Shamsuzzaman Farooq, and Kent S. Knaebel; VCH Publishers, 1994—Science. |
| Kopaygorodsky et al. “Scaling Analysis—A Valuable Technique in Engineering Teaching and Practice” Proceedings of the 2001 American Society for Engineering Education Annual Conference & Exposition Session 3513, 2001. |
| Tiep “Long-Term Home Oxygen Therapy”, Clinics in Chest Medicine, Sep. 1990, vol. 11, No. 3, pp. 505-521. |
| Dietz “international Society for Mountain Medicine: An Altitude Tutorial” Jan. 29, 2006, pp. 1-12. |
| Kumar et al. “A Versatile Process Simulator for Adsorptive Separations”, Chemical Engineering Science, vol. 49, No. 18, pp. 3115-3125. |
| Search Report for PCT Application No. PCT/US2008/073884 issued on Mar. 10, 2009. |
| Written Opinion for PCT Application No. PCT/US2008/073884 issued on Mar. 10, 2009. |
| International Preliminary Report on Patentability for PCT Application No. PCT/US2008/073884 issued on Mar. 18, 2010. |
| Search Report/Written Opinion for PCT Application No. PCT/US2011/050700 issued on May 1, 2012. |
| Search Report/Written Opinion for PCT Application No. PCT/US2013/064810 issued on Feb. 7, 2014. |
| Search Report/Written Opinion for PCT Application No. PCT/US2013/064817 issued on Jan. 10, 2014. |
| Search Report/Written Opinion for PCT Application No. PCT/US2013/064823 issued on Jan. 22, 2014. |
| Japanese Examination Report for JP Application No. 2010-524089 issued Apr. 22, 2013. |
| Japanese Examination Report for JP Application No. 2010-524089 issued Mar. 4, 2014. |
| Search Report for EP Application No. 2197530 issued Aug. 3, 2011. |
| EP Communication for EP Application No. 2197530 issued May 24, 2012. |
| EP Communication for EP Application No. 2197530 issued Feb. 5, 2014. |
| Australian Examination Report for Australian Patent Application No. 2008296606 issued Mar. 27, 2013. |
| Australian Examination Report for Australian Patent Application No. 2008296606 issued Jul. 11, 2014. |
| Search Report for EP Application No. 2613838 issued Apr. 17, 2013. |
| EP Communication for EP Application No. 2613838 issued Mar. 17, 2015. |
| Office Action for U.S. Appl. No. 12/163,549 issued May 10, 2012. |
| Office Action for U.S. Appl. No. 12/163,549 issued Aug. 14, 2013. |
| Office Action for U.S. Appl. No. 12/163,549 issued Dec. 20, 2013. |
| Office Action for U.S. Appl. No. 12/868,340 issued Oct. 10, 2012. |
| Office Action for U.S. Appl. No. 12/868,340 issued Apr. 26, 2013. |
| Office Action for U.S. Appl. No. 12/868,340 issued Nov. 7, 2013. |
| Office Action for U.S. Appl. No. 12/868,340 issued May 22, 2014. |
| Office Action for U.S. Appl. No. 12/868,354 issued Oct. 11, 2012. |
| Office Action for U.S. Appl. No. 12/868,354 issued Apr. 26, 2013. |
| Office Action for U.S. Appl. No. 12/868,354 issued Mar. 6, 2014. |
| Office Action for U.S. Appl. No. 12/868,354 issued Nov. 6, 2014. |
| Office Action for U.S. Appl. No. 12/868,368 issued Oct. 5, 2012. |
| Office Action for U.S. Appl. No. 12/868,368 issued Apr. 26, 2013. |
| Office Action for U.S. Appl. No. 12/868,368 issued Jan. 17, 2014. |
| Office Action for U.S. Appl. No. 12/868,368 issued Aug. 7, 2014. |
| Office Action for U.S. Appl. No. 12/868,368 issued Dec. 19, 2014. |
| Office Action for U.S. Appl. No. 12/868,382 issued Oct. 12, 2012. |
| Office Action for U.S. Appl. No. 12/868,382 issued May 22, 2013. |
| Office Action for U.S. Appl. No. 12/868,391 issued Oct. 5, 2012. |
| Office Action for U.S. Appl. No. 12/868,391 issued May 23, 2013. |
| Office Action for U.S. Appl. No. 12/876,848 issued Oct. 26, 2012. |
| Office Action for U.S. Appl. No. 12/876,848 issued May 23, 2013. |
| Office Action for U.S. Appl. No. 12/876,854 issued Nov. 28, 2012. |
| Office Action for U.S. Appl. No. 12/876,854 issued Jul. 18, 2013. |
| Office Action for U.S. Appl. No. 12/876,854 issued Feburary 14, 2014. |
| Office Action for U.S. Appl. No. 12/876,878 issued Nov. 9, 2012. |
| Office Action for U.S. Appl. No. 12/876,878 issued Jun. 19, 2013. |
| Office Action for U.S. Appl. No. 12/876,878 issued Feburary 5, 2014. |
| Office Action for U.S. Appl. No. 12/876,878 issued Nov. 20, 2014. |
| Office Action for U.S. Appl. No. 12/876,874 issued Aug. 22, 2012. |
| Office Action for U.S. Appl. No. 12/876,874 issued Feburary 15, 2013. |
| Office Action for U.S. Appl. No. 12/876,882 issued Dec. 6, 2012. |
| Office Action for U.S. Appl. No. 12/876,882 issued Jul. 30, 2013. |
| Office Action for U.S. Appl. No. 12/876,882 issued Oct. 8, 2014. |
| Office Action for U.S. Appl. No. 12/876,884 issued Nov. 13, 2012. |
| Office Action for U.S. Appl. No. 12/876,890 issued Nov. 26, 2012. |
| Office Action for U.S. Appl. No. 12/876,890 issued Aug. 16, 2013. |
| Office Action for U.S. Appl. No. 12/876,890 issued Mar. 12, 2014. |
| Office Action for U.S. Appl. No. 12/876,890 issued Nov. 28, 2014. |
| Office Action for U.S. Appl. No. 12/876,899 issued Dec. 21, 2012. |
| Office Action for U.S. Appl. No. 12/876,899 issued Aug. 19, 2013. |
| Office Action for U.S. Appl. No. 12/876,899 issued Aug. 28, 2014. |
| Office Action for U.S. Appl. No. 14/053,029 issued Sep. 24, 2014. |
| Office Action for U.S. Appl. No. 14/053,029 issued Mar. 12, 2015. |
| Office Action for U.S. Appl. No. 12/876,899 issued May 5, 2015. |
| Number | Date | Country | |
|---|---|---|---|
| 20150231551 A1 | Aug 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61940046 | Feb 2014 | US |
